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Abstract  
The development of a simple and rapid immunoassay approach is of tremendous 
importance for point-of-care (POC) in field diagnostics and for the surveillance of 
infectious diseases. The enzyme-linked immunosorbent assay (ELISA) is one of the most 
widely used approaches in clinical and public health diagnostics, food safety testing and 
environmental monitoring. The microfluidic technique has the advantages of 
miniaturization and integration, and has been widely exploited for use in immunoassays. 
In this thesis, a multicapillary glass plate (MCP) uniformly arrayed with microchannels 
was used as solid-phase substrate for an immunoassay. Firstly, a microdevice by the 
juxtaposition of MCP with two pieces of well-fabricated Polydimethylsiloxane (PDMS) 
slides was setup for immunoassay. The effective surface area for proteins immobilization 
was largely increased, comparing to a planar substrate or a single glass capillary. The 
micro dimension system has numerous size affection attributes, such as a higher 
surface-to-volume ratio, shorter diffusion distance and lower consumption of reagents, 
and shows greater advantages for this micro-immunoassay system. Next, PDMS slides 
with hole-array were attached onto capillary plate to form an open microarray reaction 
well. The method was then tested using saliva samples. Additionally, the PDMS polymer 
itself has been vastly popular for antibody immobilization in immunoassays. As such, a 
simple, low-cost and open PDMS microarray was exploited for its potential application 
in immunoassays. The microwell-integrated PDMS surface can be feasibly modified with 
3-aminopropyl-triethoxy-silane (APTES), which can render the native hydrophobic 
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PDMS surface less hydrophobic and to be positively charged. It has been successfully 
used in the performance of antigen capture ELISA for the detection of Rift Valley fever 
virus (RVFV) by the detection of its recombinant nucleoprotein (rNP). These results 
pointed that the open PDMS-microarray can be used for quantitative immunoassay with 
simple, sensitive and rapid assay, besides the benefits of low-cost, easy-fabrication and 
less-apparatus requirement.  
In summary, a platform based on a MCP and PDMS microarray has been developed 
for fast and sensitive micro-immunoassay. The experimental results demonstrated its 
tremendous potential and use as a diagnostic tool. This work represents the initial efforts 
towards developing a microarray immunoassay, which has the potential of high 
throughput and sensitive analysis. The developed microarray system is a simple and 
rapid device with easy performance as warranted for diagnosis of infectious diseases, 
especially in the resource-limited settings and the on-line assay. The microarray system 
can also be easily expanded to test additional samples and analytes in parallel. The 
method is noted to have excellent compatibility with routine immunoassay used in 
diagnostics, as well as high potential to be integrated into a portable system of POC and 
field testing for medical and clinical diagnosis supporting public health in the future.  
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Chapter 1. General introduction 
1.1. Background 
With the development of globalization, international affairs/cooperation and travels 
have led to a rapid spread of disease around the world and caused severe threat to human 
health. One of the most severe disasters comes from the infectious diseases, such as, 
Influenza [1], Severe Acute Respiratory Syndrome (SARS) [2], Human 
Immunodeficiency Virus (HIV) [3], Hepatitis B Virus (HBV) [4], Foot-and-mouth 
Disease Virus (FMDV) [5] and Avian Influenza (H5N1, H7N9, H10N8) [1]. Therefore, 
the development of rapid, specific and sensitive diagnosis for infectious diseases is of 
great importance. Methods for the diagnosis of infection depend on the presence of 
specific signs and symptoms, typical findings in medical imaging, or the detection of 
specific biomarkers resulting from a bacterial or viral infection [6-8]. Especially, the 
analysis of biomarkers with high specificity and sensitivity in human serum is becoming 
an increasingly critical task in medical and life sciences. It provides a capability for the 
early diagnosis in many diseases besides infectious diseases. 
Current diagnostic technologies are mainly based on immunoassay, one of the 
popular methods for biomarker measurement, and it is widely used in infectious disease 
diagnosis [9-11]. The immunoassay is a technique that is based on the formation of a 
complex between antigen (Ag) and its highly specific antibody (Ab). Then the complex 
Ag can be detected by combining with the secondary detection antibody (dAb) coupled 
with enzyme or fluorophore labels. It is widely applied in the quantification of proteins 
and small molecules in various fields such as proteomics [12], medical diagnostics [13], 
drug development [14], food safety [15-16], and environmental monitoring [17]. 
Immunoassays with high selectivity and sensitivity can be used to the precise 
determination of interest target easily and specifically. The traditional immunoassay 
method is based on 96-well microtiter plate, which takes a long time, needs large amount 
of reagents and expensive instruments [18]. Meanwhile, it is difficult to use the same 
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system or technique for the developing countries that routinely used in developed 
countries. Therefore, the development and application of low-cost, fast and easy use assay 
systems, such as POC diagnostics, hold great potentials to improve healthcare in 
resource-limited settings [19]. Enormous efforts have been applied to improve the 
practicality of immunoassay. Various materials or techniques have also been exploited in 
application of immunoassay [20-22]. Among these, microfluidic techniques play an 
important role with numerous advantages, including small size, small consumption of both 
sample and reagent, fast assay, integration and high throughput [23-24]. Therefore, the 
development of analytical devices with low-cost and sensitive platforms for fast 
diagnostics is very important. Especially, the microfluidic based system, like lab-on-a-chip 
and lab-on-a dick, provides a great potential for on-field immunoassay to meet the urgent 
global need of POC immunoassay for infectious disease diagnostics in their early stage.  
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1.2. Basic theory and practice of immunoassay  
1.2.1. Specific recognition of antibody and antigen 
Immunoassays are used to detect proteins of interest based on specific interaction and 
complex between a target Ag and an Ab, the latter being an immunoglobulin (Ig) with 
specific binding sites for the Ag. The ligand-binding methods are widely applied for the 
identification and quantification of biomarkers or other biomolecules [12, 25]. 
Antibody-based immunoassays have become the most prominent and popular assay with 
extremely low detection limits which made immunoassay a widely accepted diagnostic 
technique. Generally, an antibody is a large glycoprotein (MW~160,000 Da) that is 
produced by immune system cells (B lymphocytes) in the body in response to an 
“invading” (foreign) substance of target Ag. Abs contain binding sites in their structures 
for specific molecular recognition of the Ags. In immunoassay, like cancer diagnosis, if 
the antibodies to cancer molecules are present, it means invading cancer cells exist [26]. 
Most immunoassay systems rely upon immunoglobulin G (IgG) as an immunoglobulin of 
choice [27-29]. The basic structure of an IgG molecule is shown in Fig.1-1, it shapes a 
flexible Y structure with two identical heavy polypeptide chains and two identical light 
polypeptide chains connected by disulfide bonds [30]. The structure can be further 
subdivided into variable regions (Fab) and constant regions (Fc). Fab contains the antigen 
binding sites that vary between different antibodies. Fc is region of constant structure 
within an antibody class. The variable region of Fab possesses high specificity and affinity 
for a specific antigen which allows the detection of analyte by a variety of immunoassay 
methods. An antigen, sometimes called an immunogen, is the substance that the body is 
trying to “fight off” by an immune response. It can be recognized by the immune system 
(immunogenicity) and also can be specifically bound to an antibody (reactogenicity). 
Molecules with both immunogenicity and reactogenicity are called “complete antigens” 
and molecules that possess only reactogenicity are called “incomplete antigens”. 
Incomplete antigens, also called haptens, encompass a wide variety of molecules, 
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including drugs, explosives, pesticides, herbicides, polycyclic aromatic hydrocarbons, and 
metal ions. These haptens can induce the immune system to produce antibodies only when 
they are covalently conjugated to a larger carrier molecule such as a protein. Therefore, 
some immunoassay tests are performed with antigen detection directly instead of 
antibodies. The example is the measurement of a therapeutic drug, which acts as an 
antigen to bind with the corresponding antibody [31]. 
Antibodies are the key role in an immunoassay. There are five classes of natural 
antibodies (IgG, IgM, IgA, IgE and IgD) differed in their Fc. They mediate different 
physiological effector functions and present in serum for different half-life periods at 
different concentrations [30]. Several methods have been developed to produce Abs, 
including animal immunization, hybridoma technology, and recombinant techniques. Most, 
but not all, production methods require immunization of an animal with antigen. The 
process of making an antibody begins by injecting a solution that contains the antigen of 
interest into animals. Antibody reagents are developed from either polyclonal or 
monoclonal antibodies. Polyclonal antiserum (serum from blood containing the desired 
antibodies) is generated in animals, most commonly sheep, rabbits, or goats. Antiserum 
usually contains a mixture of antibodies that recognize and bind to the same antigen, but 
they may attach to different sites or epitopes. These types of antibodies, present as a 
diverse mixture, are called polyclonal antibodies. While monoclonal antibodies are 
produced by the hybridoma tumor cells that produce many copies of the same antibody 
and grow easily in laboratory cell culture. In immunoassays, both monoclonal and 
polyclonal antibodies are used for detecting antigens, each with specific strengths for 
particular applications [32-33]. 
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Fig.1-1. Schematic structure of an antibody (IgG molecule). Two pairs of chains form a 
flexible Y-shaped structure. The heavy chain and light chain constructed two arms are 
referred as variable region (Fab), which is the identical binding site for a specific Ag. The 
two legs of heavy chains are the constant region (Fc)  
1.2.2. Basic theory and format of immunoassay 
1.2.2.1. Immunoassay principles 
The target protein in samples can be detected by immunoassay with sensitivity due to 
the binding specificity and affinities of antibodies. Immunoassay technologies utilize 
different formats to distinguish the bound Ag-Ab complex from the free unbound label. 
The immunoassay methodologies are divided into noncompetitive and competitive 
immunoassays depending on the formats of Ab-Ag recognition or homogeneous and 
heterogeneous immunoassays according to the separation requirements [34-35]. The 
formats are schematically illustrated in Fig.1-2. 
To competitive formats (Fig.1-2a), the detecting antibodies (pre-titrated and labeled 
Ab) are simultaneously added with sample (competing Ab), two competitors are 
competing to bind to the surface bound Ag. The target Ab in sample is measured relying 
on its ability to compete with labeled Ab. Due to the occupation of targets to the bonding 
sites, the less labeled Abs bounded means the more target Abs present. Thus, the amount 
of Abs in the test sample is inversely related to the amount of the labeled Ab in the 
competitive format. While Fig.1-2b illustrated the quantification of Ag by simultaneous 
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incubation with free Ag (sample) and labelled Ab, the surface-bound Ag and free Ag are 
competing to bind to Ab. Noncompetitive assay formats generally provide the highest 
level of assay with sensitivity and specificity. This format can be separated into three 
modes, including direct assay (Fig.1-2c, 1-2d), indirect assay (Fig.1-2e) and “sandwich” 
assay (Fig.1-2f, 1-2g). They are widely applied to the measurement of critical analytes, 
like biomarkers, because of its highly specific bound to Abs. Additionally, wash steps 
render to isolate and remove the excess unbound labeled reagent and any other interfering 
substances.  
On the other hand, homogeneous immunoassays are separation-free, while the 
heterogeneous immunoassays require separation of the bound Ab-Ag complexes. The 
former is generally competitive in solution and have been applied to the measurement of 
small targets such as abused and therapeutic drugs [34, 36]. Since homogeneous methods 
do not require the separation of the bound Ab-Ag from the free Ag, they are generally 
much easier and faster to perform, in which the signal is directly obtained from a mixture 
of the test sample. However it is less sensitive than heterogeneous assay methods.  
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Fig.1-2. Schematic illustration of the formats for immunoassay. Competition assay (a, b); 
direct assay (c, d); indirect assay (e); sandwich immunoassay (f, g). 
1.2.2.2. Labels for detection 
Most of the immunoassays require the use of labeled material in order to measure the 
amount of Ag or Ab present. The label can be applied during the manufacture of the 
reagent to either the Ab or Ag. A label is a molecule that will react as part of the assay, so a 
change in signal can be measured. Examples of a label include a radioactive compound 
[37], an enzyme such as horseradish peroxidase (HRP), glucose oxidase (GOx) or alkaline 
phosphatase (AP) [25, 38-39], fluorophores like fluoresceine isothiocyanate (FITC) and 
Indocarbocyanine (Cy3) [35, 40] or a substance that produces light (e.g., 
Chemiluminescent substrates) [41], as well as nanoparticles (e.g., Quantum dots) [42].  
（a） （b） （c） （d）
（e） （f） （g）
substrate
antigen
labeled antigen
antibody
labeled antibody
substrate solution detectable products
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In the areas of safety regulations, instrumentation and convenience of protocol, 
enzyme immunoassays have easily surpassed others. Enzyme catalyzed immunochemical 
test had caught the imagination of researchers leading to development of numerous 
immunoassays over the years. The future of enzyme immunoassays will bring more rapid 
test results with simplified procedures catering to wider audience for clinical applications. 
Among the enzyme label format, enzyme-linked immunosorbent assay (ELISA) is much 
more popular. When using an enzyme label, it is important to understand the kinetics of 
the particular enzyme with the chosen enzyme substrate. From which, the identity and 
concentration of enzyme substrate can be appropriate chosen. For ELISAs, either Abs or 
Ags are immobilized on a solid phase to facilitate the separation of free and bound 
fractions, finally with a color change based on corresponding substrate for detection.   
1.2.2.3. Sandwich immunoassay 
In sandwich immunoassay, the target Ag with two epitopes is ‘sandwiched’ between 
two types of Abs, which are often called capture and detection Ab (cAb and dAb) 
respectively. That’s why the sandwich immunoassay offers one of the highest selectivity 
for an immunoassay. In a typical sandwich immunoassay, cAb is bound to a solid support, 
normally a polystyrene plate, while a second antibody labelled with an enzyme or 
fluorescent dye is used for dAb in signal detection. The solid support could be a number of 
materials such as microbeads [43], planar surfaces (e.g. plastic well plates, glass slides, 
etc.) [44-45] and membranes [46], etc. The antibodies could be immobilized onto these 
surfaces either covalently or non-covalently (also known as physisorption). Sandwich 
immunoassay, one format of heterogeneous assay with multistep washing, is the most 
widely used method for protein molecule or biomark assay. It involves the immobilization 
of cAbs to the solid substrate surface, following by the treatment of blocking with 
blocking reagents to eliminate non-specific adsorption of molecules and to increase the 
assay selectivity. Next, the cAbs are exposed to an Ag-containing sample solution to form 
cAb–Ag complexes by specific binding. After incubation and washing, the labelled dAbs 
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are applied. Then, the unbounded proteins are washed away. Following with formation of 
the sandwich complex, Ags are detected depending on the labels present on the dAbs. The 
procedures are schematically illustrated in Fig.1-3, a typical sandwich immunoassay 
procedure. 
 
Fig.1-3. Multistep procedures for sandwich immunoassay. 
1.2.3. Detection techniques for immunoassay 
Immunoassay detection commonly relies on the labeled Ab or Ag. Various types of 
detection techniques have been developed according to the labels, such as radiochemical, 
optical, electrochemical methods. Radioimmunoassay offered advantages over ELISA, but 
it was limited for the expensive experimental instrument required, demanding reaction 
condition and harmfulness from radioactive isotopes [37]. Recently, electrochemistry 
based immunoassay has got increasingly interest with the micro fabrication technique 
developed [47-48]. However, the most simply and easily performed detection method is 
cAbs
coating
washing
blocking
washing
Ag
catching washing dAbs
binding
washing
substrate
reaction
solid substrate
capture antibody
blocking reagent
antigen
detection antibody
substrate solution
detectable products
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optical method, change of the color upon the reaction of substrate and enzyme can be 
readily read by eye [22]. Most often coupled with colorimetric detection [39], fluorescence 
[49-50], chemiluminescence [51]. By the way, there are also other immunoassay 
techniques available for Ag detection that in principle do not require any label. For 
example, surface plasmon resonance (SPR) [52-53], electrochemical detection [54-55], 
Raman Spectrum [53]. In these systems, cAbs are always immobilized onto a functioned 
solid surface, which provides the detection signal owing to the Ab–Ag immune-complex 
formation.  
Qualitative and quantitative assays can be carried out in an immunoassay. Generally, 
qualitative assays provide results of simple negative or positive for a sample of interest. In 
performance, two or three times the standard deviation (error inherent in a test) is usually 
established to distinguish positive sample from negative. While, quantitative analysis is 
based on a comparison of signal from the samples with unknown target concentration to a 
standard calibration plot. The plot is made from a serial dilution of a known concentration 
solution of the target. 
1.2.4. Coating methods and effects 
To establish a specific, sensitive and stable immunoassay, many aspects have to be 
considered for assay-optimization because of the multiple steps of assays and their 
variability of material and methods. Among them, the most vital one is cAbs coating. After 
coating, protein conformation should be intact so that protein functions are retained for a 
high-performance, reproducible assay. Various methods and reagents have been developed 
and applied for coating Ab in immunoassay, commonly performed as following. 
1.2.4.1. Physical adsorption 
In solid phase immunoassay, i.e. heterogeneous immunoassay, the coating of the 
cAbs is the primary and definitive step in the total assay. Thus, lots of coating methods 
have been employed to immobilize cAbs to the solid surface. An excellent review on 
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immobilization strategies for protein microarrays is provided by Dohyun Kim [56]. 
Generally, an efficient coating method relies on a variety of factors mainly including solid 
surface, sample matrix, protein property and buffer conditions. The simplest approach to 
immobilize proteins on a surface is physisorption (i.e., physical adsorption). Proteins can 
be easily adsorbed onto various solid surfaces via intermolecular forces such as 
electrostatic, hydrophobic, van der Waals, hydrogen bonding interactions, or combination 
of those [57]. There is no chemical reaction ether incubation of proteins on solid surfaces 
or continuous flow for attachment of protein. Although the low degree of protein coated, 
many studies have employed physisorption of protein to an assay [58-59]. Some 
advantages contribute to the popularity of the approach in terms of simple assay procedure, 
no toxic reagents and no sophisticated chemical protocols. The intermolecular forces are 
highly dependent on environmental conditions, like pH, ionic strength, temperature, and 
surface condition [57]. The traditional polystyrene (PS) plastic known as 96-well plate and 
Polydimethylsiloxane (PDMS) are widely used to adsorb proteins onto the bare surface 
based on the hydrophobic nature of these substrates [58]. Researchers have taken some 
efforts in solid surfaces modification to supply more hydrophobicity for protein adsorption 
better than the native surface. However, the random adsorption by physisorption may lead 
to desorption during the intensive washing steps, as well as the higher non-specific 
interaction.  
1.2.4.2. Chemical bonding 
Physical adsorption can reduce antibody binding activity because of unfavorable 
orientation, steric hindrance and denaturation [60]. To vent these challenges, many 
covalent immobilization strategies have been developed, which are involve chemical 
interaction between cAbs and the surface pre-modified molecules. Darain et.al. developed 
a simple microfluidic immunoassay card based on polystyrene (PS) substrate for the 
detection of horse IgG. The primary antibody was captured onto the PS by covalent 
bonding via a self-assembled monolayer (SAM) of thiol to pattern the surface chemistry 
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on a gold-coated PS [61]. Covalent bonds are frequently used in protein immobilization, in 
which the surface is activated via reactive reagents. Due to the amino groups (-NH2) of 
lysine residues which are usually present on the exterior of proteins, the covalent binding 
can be completed by an active group terminated molecular. An enormous variety of 
covalent conjugation chemistries are available. One example is a bis-aldehyde compound 
of Glutaraldehyde (GA) that has two reactive ends. Which can crosslink two amine 
functional groups, between two proteins or between a protein and a surface-immobilized 
polymer with amine groups (e.g., Polyetherimide, PEI). For use of glass or silicon, the 
hydroxyl functioned surface can bind to one end of aminosilane compounds like 
(3-aminopropyl)triethoxysilane (APTES), which possess an amine functional group to 
facilitate covalent linkage with proteins on the other end [62].  
1.2.4.3. Bioaffinity binding  
Alternately, a protein immobilization strategy that relies on bioaffinity has also been 
drawn much attention, because of the relatively stronger, highly specific, and oriented 
protein immobilization by a bioaffinity interaction. Moreover, the binding interaction is 
rapid and nearly insensitive to pH, temperature, proteolysis, and denaturing agents. 
Nishizawa et.al. constructed a biointerface for highly sensitive immunoassays by 
preparing a phospholipid polymer to immobilize specific antibodies through covalent 
chemical bonding [63]. Another most widely employed immobilization partners is avidin 
(tetrameric glycoprotein) and biotin (water-soluble vitamin B) [64-65]. Avidin binds to 
biotin via an exceptionally strong non-covalent interaction [66]. Biotin is a small molecule 
and conjugation to proteins does not significantly affect protein functionality or 
conformation. Usually, bioaffinity interactions conjugated with other binding mechanism 
(i.e., physic sorption or chemical bonding) are used in Abs immobilization, with the 
bioaffinity reagent acted as an intermediate binding molecule between the surface and 
proteins. For example, Yuan et.al. developed a signal amplificatory electrochemical 
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immunoassay with biotin-streptavidin conjunction and multienzymatic-based substrate 
recycling for h-IgG measurement [67].  
1.2.4.4. Effects of reagents and buffers  
Generally for ELISA tests, all buffers, blocking solutions and standards should be 
carefully stored to avoid the changing or losing of their chemical or biological activity. 
The important buffers are dilution buffer, wash buffer, coating and blocking buffer. A 
correct physiological condition is very important for immunoassay according to the 
biological natures of the antibodies and enzymes. The goal of buffer selection is to obtain 
stable and sensitive assays with low standard deviation and low background. In order to 
reduce unspecific binding on coated plate, a blocking was often performed with addition 
of different kinds of proteins or protein mixtures. Albumin is commonly used as blocking 
substance and also smaller proteins like casein for example were used for blocking. 
Effective blocking could significantly reduce the unspecific binding but a blocking could 
also cause increased background. In general, the blocking substance should not interfere 
with the ELISA system. For example, BSA should not be used as blocking agent, if the 
antibody was generated with hapten-BSA conjugate. 
1.2.5. Materials used for immunoassay 
Effect of antibody immobilization on the solid surface can dramatically influence the 
performance of a surface-based immunoassay. Therefore, numerous materials have been 
exploited to improve the immobilization. The traditional material is PS, which are widely 
used in 96-well microtiter plate [68]. Additionally, PS-based microparticles with fast and 
sensitive assay are also widely used for immunoassay by taking advantages of small size 
and large surface area. Meanwhile, surface treated PS microbeads with carboxy group 
(-COOH) [43] or gold layer [61] are exploited to immobilize proteins by chemical 
bonding instead of physisorption. Glass, a common and low cost substrate is also widely 
used as substrate for immunoassay. Glass substrates benefit from immobilization 
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chemistries including various silanol chemistries for covalent linking of proteins besides 
the simple physical adsorption. Interestingly, glass plate fabricated device or glass based 
capillary are also widely used. A mentionable one is the glass-polymer integrated 
microfluidic devices, which have been increasingly developed and widely used in 
immunoassay [69]. Besides, capillary glass also performs a great tool with easily 
flow-handling in immunoassay [70]. Hisamoto group developed a highly sensitive 
capillary-based ELISA using a square capillary. The method was used for the analysis of 
thrombin-cleaved osteopontin, a potential biomarker for ischemic stroke, in human plasma 
[71]. Yacoub-George et.al. reported an automated 10-channel capillary chip 
immunodetector prototype. They used a disposable capillary chip containing 10 
fused-silica capillaries arranged in parallel coated with selected capture antibodies for 
automatically operated biological agents point detection [72].  
Polymers (e.g., PDMS), which is currently one of the most frequently used and 
studied substrates in microfluidics, is increasingly applied in immunoassay owing to easy 
fabrication, non-toxicity and optical transparency. As related to protein immobilization, 
proteins are readily binding to PDMS surface because of the native hydrophobic form. But 
high nonspecific bond should be reduced by blocking. Though, PDMS lacks functional 
groups for covalent derivatization, it can be modified with functional groups, such as 
silanol, carboxyl, amino and isothiocyanate. This approach can greatly improve the 
performance of PDMS in microfluidic device and microarray applications [73]. 
Additionally, Poly(methyl methacrylate) (PMMA) and cyclic olefin copolymer (COP) [74] 
are also used as solid substrate for immunoassay. Other materials, such as paper or 
membrane have also been gained attention for immunoassay owing to low chip material 
and manufacturing costs. Especially, paper based POC systems for low-resource settings 
owing to low cost, simple assay visualization, and simple reagent immobilization are 
widely used for clinical assay [20, 22, 75].  
In view of large surface area, high surface-to-volume ratio and fast diffusion, 
micro/nano beads are also got great attention in immunoassay. Magnetic beads can be 
manipulated and separated using a magnetic field, which strongly facilitates assay 
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protocols in immunoassay [76]. What’s more, various forms of silica beads, sol-gels, 
agarose beads, hydrogels and polymer monoliths are also exploited for immunoassay with 
excellent performance. Kim, et.al. has reported a review in which materials for 
immunoassay are summarized [77].  
1.3. Applications of immunoassay 
Immunoassay as an important analytical tool, has attracted substantial attentions with 
the expectation of obtaining prompt, accurate, and sensitive immunological response to 
analytes of interest. The methods have been widely applied in medical and clinical 
diagnosis, food safety as well as environmental monitoring field, due to its high selectivity 
and sensitivity. Some examples are discussed in the following. 
1.3.1. Medical and clinical diagnosis  
Sensitive and selective detection of disease biomarkers is of great importance for 
early diagnosis, personalized treatment, and molecularly targeted therapy of major 
diseases. Detection of biomarkers in body fluids and some tissues, such as blood, urine, 
saliva and tear, play an important role for medical and clinical diagnosis. Consequently, 
techniques and methods with high sensitivity and selectivity are required to detect the 
corresponding marks for early diagnoses of these diseases. In view of these, immunoassay 
is a powerful and credible method allowing quantification and monitoring of small 
molecules, large proteins and even whole pathogens. As is well-known, simple and rapid 
immunoassays such as lateral flow strip tests have been used in clinics and can be 
available over the counter for home use.  
Chuang et.al. used ELISA method to detect the pyrethroid biomarker, 
3-phenoxybenzoic acid (3-PBA) in human urine samples, it showed that the results of the 
ELISA was highly correlated with GC/MS data with a correlation coefficient of 0.95 [78]. 
Lee et.al. presented a system for rapid quantification of vitamin D levels on a smartphone. 
The system consists of a smartphone accessory, an app, and a test strip that allows the 
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colorimetric detection of 25-hydroxyvitamin D using a novel gold nanoparticle-based 
immunoassay [79]. Accurate, sensitive, multiplexed detection of biomarker proteins holds 
significant promise for personalized cancer diagnostics. Otieno et.al. described the 
incorporation of a novel on-line chamber to capture cancer biomarker proteins on 
magnetic beads derivatized with 300,000 enzyme labels and 40,000 antibodies into a 
modular microfluidic immunoarray [80]. The on-line capture chamber facilitates rapid, 
sensitive, repetitive protein separation and measurement in 30 min in a semi-automated 
system adaptable to multiplexed protein detection.  
1.3.2. Food and environment assay 
The remarkable specificity of the Ab-Ag interaction and the ability to detect analytes 
in complicated sample matrices has attracted researchers in area of food and environment. 
Food safety is critical to the food industry, and common analyses include food 
adulteration testing, meat species identification and insect infestation testing. Food is also 
inspected for the presence of hormones, insecticides, herbicides, antibiotics, and drugs, all 
of which can be detected with immunoassay. For instance, Escherichia coli O157:H7 is a 
major foodborne pathogen that has posed serious problems for food safety and public 
health. Recent outbreaks and recalls associated with various foods contaminated by E. coli 
O157:H7 clearly indicate its deleterious effect on food safety. A rapid and sensitive 
detection assay is needed for this harmful organism to prevent foodborne illnesses and 
control outbreaks in a timely manner. M. Aydin et.al. developed a magnetic bead-based 
immunoassay for detection of E. coli O157:H7 with a 96-well microplate as an assay 
platform [15]. Xu et.al. developed a semiquantitative strip immunoassay for the rapid 
detection of imidacloprid and thiamethoxam in agricultural products using specific 
nanocolloidal gold-labeled monoclonal antibodies [81]. Consumption of foods 
contaminated with drug residue is a major public health concern, a sensitive 
biotin-streptavidin amplified ELISA method was developed by S. Wang group for the 
determination of chloramphenicol residues in milk [66]. Immunoassay may be a valuable 
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tool to the detection of trace targets and could be widely used for routine monitoring of 
food samples. 
Because of the complicated environment samples contain many possible interferents, 
the technology and approach with high selectivity for targets are of importance. 
Fortunately, immunoassay based methods with capture Abs are facile to it. For example, 
Bisphenol A (BPA), a xenoestrogenic endocrine-disrupting chemical used in many 
consumer products worldwide, is widely detected in the environment and in food. F. Long 
et.al. developed an all-fiber optofluidics-based bioassay platform combining the 
advantages of evanescent wave fiber optic sensor and microfluidic technology, for the 
rapid immunoassay and assessment of BPA [82]. An indirect competitive 
biotin-streptavidin-amplified ELISA for Tetrabromobisphenol A (TBBPA), a widely used 
brominated flame retardant, was reported. The results are consistent with those using 
liquid chromatography and the method is suitable for the rapid and sensitive screening of 
TBBPA in environmental monitoring [83]. Feng et.al. focused their interests on the 
development of immunoassay-based fast scanning methods for persistent organic 
pollutants. They developed the Ab of polybrominated diphenyl ether (PBDE) and realized 
the measurement of it by competitive indirect ELISA [84]. 
1.4. Current development of immunoassay and issues  
1.4.1. Current development of immunoassay 
The original immunoassays were developed to study immunology, particularly the 
Ab-Ag interactions. As it demonstrates the advantages and performing actions, 
immunoassays aiming at high sensitivity, selectivity and accuracy, have been achieved. 
And developed assay systems have been widely applied in various fields.   
However, conventional immunoassays (using a 96-well microtiter plate) are often 
reagent-wasting, time-consuming and require expensive instruments. It sometime also 
needs high skills. Even though, some modifications based on 96-well plate have been done 
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to improve the sensitivity or decrease the assay time. Dixit et.al. reported a rapid sandwich 
ELISA by pretreating the microtiter plate surface with 3-APTES, followed by the covalent 
bonding of cAb for highly sensitive detection of a biomarker [85]. Besides, Kai et.al. 
introduced a novel microfluidic ELISA microplate as the next generation assay platform 
by integrating the benefits of microfluidic technique with the conventional microplates. It 
allows for the improvement of ELISA workflows, conservation of samples and reagents, 
improved reaction kinetics, and the ability to improve the sensitivity of the assay [86]. 
Recently-developed methods for an enhancement of sensitivity are most based on the 
following approaches or technologies, including 1) surface modification for cAbs bonding 
[87]; 2) nanoparticle or quantum dots (QDs) application [88-89]; 3) enhancement of target 
Ag [90]; 4) detection methods [91-93] and so on. Interestingly, capillary electrophoresis 
(CE) [71] and affinity CE immunoassays [50], mostly in competitive homogeneous 
formats, are also exploited for biomarkers detection. Additionally, microarrays are a 
powerful technique in the multi assays [94]. Especially, with the inkjet of micro-printing 
technology introduced, the fabrication of microarrays is easily performed.  
In the last decades, microfluidic devices have received much attention, due to their 
competitive advantages, especially in regards to low sample/reagent consumption, short 
time, easy integration and high throughput [49]. Recently, microfluidics development 
continues to rapidly exploiting of immunoassay because of the wide variety of biosensor 
platforms and applications [74]. Microfluidic based devices are largely scaled down the 
assay system, resulting in a miniaturized lab, known as lab-on-a-chip (LOC). One way of 
circumventing problems associated with conventional immunoassays is miniaturized in 
microfluidic systems. The integration of immunoassays into microfluidic techniques has 
great potential to provide significant reductions in terms of assay time and cost. 
Microfluidic-based immunoassays have superiority over conventional methods, including 
a) large surface-to-volume ratio for speed up Ag-Ab reaction; b) small diffusion distance 
for fast diffusion; c) micro dimensions for small consumption of reagents/samples; and d) 
capillary actions for flow handling. These benefits can potentially improve the 
performance and reduce the operating cost of conventional immunoassays. Immunoassays, 
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with their high affinity and specificity, show the most promise for implementing such a 
system. A single channel system on a chip has been designed, developed for the detection 
of thyroid stimulating hormone (TSH). Test results were obtained within 30 minutes after 
a sample was dropped into the POC cartridge [21]. Lab on a disc was also got interest with 
merits of no-pump injection, high throughput assay, easy integration. Kim et.al. presented 
a novel fully integrated centrifugal microfluidic device with features for target antigen 
capture from biological samples, via a bead-based ELISA, and flow-enhanced 
electrochemical detection. The measurement for C-reactive protein (CRP) got a low LOD 
to be 4.9 pg/mL, less than 20 min [47]. Numerous examples can be found in periodical 
database. Diagnostics not only for initial diagnosis but also for monitoring, especially 
toward personal monitoring, the integration of diagnostics/therapeutics with microfluidic 
systems can offer big benefits to worldwide health.  
One of the most exciting applications of microfluidics-based diagnostics is its 
potential use in next generation POC devices [23]. The idea with POC is that the 
analytical sample (blood, urine, saliva etc.) can be loaded to the test point and results can 
be received almost directly. Compared with chip-based analytical devices, paper-based 
ones are simpler to design, easier to manufacture and use, and more affordable [22, 95]. In 
addition, paper-based analytical devices are coupled with a colour change, which can be 
visualized with the naked eye [22, 96]. The most successful development is lateral flow 
assays, which have traditionally been applied to analytes that do not require very high 
analytical sensitivity or quantitative results [97]. In recent years, lateral flow 
immunoassays (LFIA) have been indicated as a suitable medical diagnostic tool for these 
environments because they require little or no sample preparation, provide rapid and 
reliable results with no electronic components and thus can be manufactured at low costs 
and operated by unskilled personnel [97]. There are a range of commercialized products 
for diabetes, pregnancy testing and sexually transmitted diseases. These tests give a simple 
positive or negative answer through the actions of micro-structured capillaries and 
chambers with dry reagents. Recently, POC testing of biomarkers in clinical samples has 
been of great importance for rapid and cost-effective diagnosis [48]. Though a number of 
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immunoassays utilizing lateral-flow strips, lab-on-a-chip and paper-based devices have 
been developed, there is also an increasing demand for convenient and accurate POC tools 
that can detect and diagnose different stages of a disease in remote or impoverished 
settings. 
1.4.2. Issues 
Current development of immunoassay has been got a great improvement in term of 
assay time and limit of detection. Especially, the idea of POC promotes vast requirements 
of portable and disposable systems to be used for fast and field immunoassay. In view of 
these, micro/nano particles with large surface area and short diffusion distance have been 
popular and widely used for immunoassay. However, the problems are the complicated 
performance and the extra instruments needed in washing step for B/F separation. 
Meanwhile, membrane or papers are another popular materials used in immunoassay, 
which supply the benefits of no sample treatment and fast assay with eye-read based on 
color change. While for precise and quantitative assay, they are not competent. Recently, 
the speedily developed microfluidic technique has been facilitated the advance of 
immunoassay on a card-size chip, i.e. lab-on-a-chip. Because of the extremely 
dominating characteristics including small size, high surface-to-volume ratio, integration 
and high throughput detection, various efforts have been taken to combine immunoassay 
with chip system cost efficiency and high sensitive applications. However, issues are 
coming from the limited surface area due to a single microchannel used for working 
space, and the lack of high density detection as performed on a 96-well plate. Thus, much 
more powerful and efficient systems are required in POC field, especially the prompt 
spread of infectious disease in the world.  
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1.5. Theory of the micro-immunoassay 
1.5.1. Immunoassay based on the 3-D structure 
As an immunoassay performed on a planar surface, such as a glass or plastic slide, or 
a single micro-channel, the limited working space with a monolayer immobilized protein 
cannot afford enough analytical signals, may lead to low detection limit. One of the virtual 
conditions for high sensitive assay is the immobilization surface. An ideal immobilization 
surface should have a large surface-area-to-volume ratio, a protein-friendly environment, 
minimal nonspecific protein adsorption, mechanical and chemical stability, and a reactive 
moiety for protein coupling. Among them, material integrated system used for 
immunoassay is an ignorable parameter, which effect surface characteristics, 
surface-to-volume ratio, unspecific adsorption, analytical time and so on. In view of these, 
microfluidic device and/or three-dimensional (3-D) structure have been widely studied to 
improve the performance of immunoassays. The microfluidics based immunoassay were 
discussed in the former part, here some advantages and practices of 3-D system for 
immunoassay will be talked.  
In contrast to a planar immobilization surface, 3-D surfaces always supply numerous 
advantageous. Commonly, the 3-D formats include micro/nanostructures created using 
nanoparticles [88, 98], microbeads [99-100], hydrogels [101], sol-gels [102], polymer 
monoliths [103], and membranes [104]. Fabrication approaches for these 3-D structures 
vary greatly, depending on the material choice and properties needed. The increased 
effective surface area found in the 3-D material offers a larger number of immobilization 
sites, as compared to planer surface or a channel wall (2-D) system. Most importantly, the 
diffusion length between reaction partners (e.g., Ab and Ag, or enzyme and substrate) in a 
3-D structure is greatly reduced, besides the large surface-to-volume ratio. Therefore, high 
efficient reaction and fast diffusion lead to a high analytical sensitivity and fast assay. Li 
et.al. prepared a 3-D biochip composed of a glass microscopy slide arrayed with amino 
aerogel dots, the 3-D mesoporous structure surface contained amino functional groups 
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capable of performing a sandwich immunoassay. The primary antibody was immobilized 
on the internal surface of the arrayed amino aerogel to capture its affinity antigen. In 
comparison to the corresponding two-dimensional (2D) biochip, the 3D amino aerogel 
biochips were observed to amplify signal intensities more effectively due to their 
remarkable capturing capability [105]. Charles et.al. reported the fabrication, 
characterization and evaluation of 3D hydrogel thin films used to measure protein binding 
(antigenicity) and antibody functionality in a microarray format [106].  
1.5.2. Microarray 
Additionally, microarray technology is an essential analysis tool used in modern 
biological and biomedical research because the microarray-based analytical strategy is 
quicker and more convenient than serial testing for individual analytes [107-108]. It has 
already been widely used in proteomics and genomics owing to site-specific 
immobilization and simultaneous interrogation of numerous of biomolecules on a single 
substrate. Due to the ability for rapid, highly parallel analysis of targets in samples, it is 
popular in various biological assays, such as pathogen detection [108], drug discovery 
[109], gene screen [110], immunoassays [111], proteomic studies [112] and so on. For 
instance, Han et.al. prepared protein micropatterns for microarray-based multiplex 
bioassays with enhanced protein-loading capacity and detection sensitivity. The system 
enabled the simultaneous performance of multiple immunoassays on a single microarray 
platform [113].  
Generally, the conventional technologies used to manufacture microarray can be 
classified into three categories: contact printing, in situ synthesis, and non-contact inkjet 
printing. While due to some disadvantages, like sophisticated instruments required, special 
chemicals and reactions demanded, droplet evaporation, much more efforts have been 
recently taken in the microfluidic-based techniques for microarray fabrication. DNA or 
protein microarrays in a cost-effective and flexible manner, including line-printing and 
spot-printing are the good examples. Even though, in order to realize POC applications, 
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there is still a great need for development of new microarray fabrication techniques, 
requiring low production cost, simplicity, flexibility, and disposability for use in common 
laboratories or resource-poor settings. 
1.5.3. Capillary action and its application to micro-immuoassay 
The miniaturization and low-cost diagnostic devices are largely demanded, which 
demonstrates that the integration of diagnostics with microfluidics as POC testing is 
greatly promising for an easy and accurate operation. Especially, multistep immunoassays 
including serial reagents flow in and flow out are still challenging. Thus controlling 
flow/stop performance inside the micro-channel is an important issue in terms of 
simplifying the procedure via omitting extra driving-pumps or valves. Interestingly, 
capillary action in microfluidics offers a great potential for liquid flow-handling to 
improve solution transportation due to the microsize of the micro-channel. Therefore, 
many techniques integrated capillary action with microfluidics have been exploited in 
immunoassay. One simple and well-known example is the paper/membrane based 
immunoassay, like lateral flow immunoassay [114-115]. Another example reported by He 
et.al., they developed a disposable polymeric microfluidic device containing capillary 
force driven microfluidic channels with embedded electrowetting valves and a porous 
membrane. To conduct the assay, the microchip was connected with a low voltage supply 
which was capable of sequentially opening the valves, sample/solution were delivered into 
the micro-channel consequently to generate visual results [116].  
1.6. Thesis organization 
This thesis consists of 6 chapters. Chapter 1 provides the general introduction of 
basic immunoassay, scientific and technical background to micro-immunoassay. The 
aims of this part are to allow the readers to understand the basic concepts, the previous 
work that laid the foundation for this work. Chapter 2, Chapter 3 and Chapter 4 are the 
works based on multicapillary glass plate (MCP), and Chapter 5 is extended to a PDMS 
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open-array based on the microsystem. The four chapters are the main parts of this thesis 
and are systematically discussed, respectively. Briefly, Chapter 2 introduces the principle 
of the work which is based on the 3-D system, and the design of the microdevice for the 
performance of immunoassay. Chapter 3 discusses the validation of the design based on 
the principle of the former part. Then a comparison between the proposed microdevice 
system and the traditional 96-well plate method is also discussed. In this part, a novel and 
accelerated ELISA with MCP-assembled microfluidic chambers was developed for 
immunoassay. The micro-dimension and large surface area of the MCP permits the 
diffusion distance to be decreased and the reaction efficiency to be increased. To confirm 
the concept of the method, human immunoglobulin A (h-IgA) was measured using both 
the present immunoassay system and the traditional 96-well plate method. In Chapter 4, 
the exploitation of MCP-based microdevice is discussed and it was successfully applied 
to saliva sample measurements. Here, a highly sensitive and rapid immunoassay in 
multi-channels of a micro-well array consisting of a MCP and PDMS slide is described. 
Various conditions were investigated to confirm the validation of the micro-system for 
immunoassay. The results suggested that this method has tremendous potential for use in 
automated and on-site immunoassays. Chapter 5 discusses the development and 
construction of a simple and open PDMS microarray used for the immunoassay. The 
microarray integrated portable system could be a great potential for on-field, POC and 
real-time applications in biological and clinical assay. Chapter 6 summarizes the 
principal findings, and its potential contributions to the field of laboratory diagnostics of 
infectious diseases and its directions for future work in revolutionizing the diagnosis of 
infectious diseases.  
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Chapter 2 Principle of micro-immunoassay in MCP and 
fabrication of the 3D microarray device 
2.1. Introduction 
With the advent of globalization, growth in international affairs or travels is 
occurring simultaneously with the unprecedented risk of pandemic disease emergence 
[1-2]. The movement of human and inadvertent transport of animals or plants result a fast 
spread of infectious diseases [3]. Especially the great development of aircraft travel and 
shipborne trade, a tremendous threat will be continuous appeared for communicable 
disease, via vector-borne disease, human-incubated pathogens, or insect vectors [4-5]. 
Briefly, the world’s major pandemics include plague, cholera, influenza, HIV/AIDS, 
severe acute respiratory syndrome (SARS), bioterrorism and so on [6-8]. A typical 
example is the H7N9, a novel avian influenza A virus, which is an animal-borne 
emerging infectious disease broke out last year in China [9], and led to a great damage in 
human health and economic. Therefore, fast and sensitive clinical methods are urgently 
demanded for early diagnostics to decrease threats of these pandemic diseases.  
As is well known to all, proteins can act as biomarkers to differentiate between 
health and diseases in clinical diagnostic. They are conventionally detected by 
immunoassays, especially the ELISAs, which are widely employed in current clinical 
diagnostic tests and research applications [10-12]. The technique is based on the selective 
absorption of proteins to the immobilized antibodies due to the specific epitopes on 
antibody molecule. A lot of efforts have been taken to identify these diseases in their 
early stage and realize fast clinical diagnostics. The traditional ELISA is performed on a 
96-well microtiter plate [13]. Sometimes, a 384-well [14] or 1536-well [15] microtiter 
plate is also used for screen in immunoassay. The benefits from these number wells of 
plate are the parallel and high density measurements. However, it is the most labor 
intensive and sample/reagent consumption, as well as time cost. Recently, to circumvent 
the forementioned problems, various new materials and techniques have been exploited 
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and developed with the aims of simplifying and improving the performance of 
immunoassays. Especially, microbeads [16], magnetic nanoparticle [17], gold 
nanoparticles [10, 18] or CNTs [19] are the popular solid surface alternative to the 
micro-well plate for immobilization of antibody, because of the merits of large surface 
area and short diffusion distance for sensitive and fast assay. While, the complicit process 
and rigorous washing for separation led them difficult for routinely use. On the other 
hand, the recent developed microfluidic technique is easily facile to the aims of 
miniaturization, integration and high throughput detection, as well as serial and multiple 
assays. Various merits of small size, flow handling, high surface-to-volume ratio and 
small diffusion distance have attracted significant attention in immunoassay with low 
consumption, fast assay and sensitive detection etc. [20-22]. Interestingly, there is an 
improvement of 96-well plate by integrating a microcapillary circle to each well’s bottom 
of the plate for ELISAs based on microfluidic technique [23]. While the integration of 
microsphere with microfluidic chip was also reported [24], Mai Ikami et al. presented an 
immune-pillar based chip with multiple antibody molecules immobilized onto 
polystyrene beards, which were constructed into the PEG pillars in the chip channels for 
fast multiplex immunoassay.  
However, the integration of all or most of their advantages for immunoassay will be 
a great exciting improvement. In view of these, a 3-dimensional (3-D) microarray in this 
work was designed and validated for immunoassay. The 3-D microchannel system with 
its characteristics of micro size, large surface area and high ratio of surface-to-volume 
can supply comparable advantages to microparticle or microfluidic chip. Meanwhile, the 
micro-array provides a density and parallel detection technique which is the bright point 
of 96-well plate. The combination of those advantages, not only brings rapid and 
sensitive analysis due to fast diffusion, but also leads to low sample/reagents 
consumption with the microsize, and the simple performance by flow through solutions. 
Due to the relative fast molecular diffusion in microdimension with flow-based method, 
the analytical time will be greatly decreased [25]. While when the system combined with 
35 
 
microfluidic technique, the solutions can be constantly refreshed by delivering fresh 
solution, which will influence the rate of adsorption.  
Here, we first use MCP in combination with PDMS chip tandem microfluidic 
techniques for fast and efficient immuonassays. The basic principle of 
micro-immunoassay performed onto MCP system will be discussed and design of the 
system will be described. MCP can be preferred due to its high ratio of surface area to 
volume and flow-based system because of the powerful compact microcapillaries. 
Meanwhile, the delivery of multiple reagents for multistep ELISA reaction was carried 
out by a syringe pump. The flow-based method for reagent injection can simple the 
practical procedures and enhance the measuring speed. It allows shorter assay time due to 
the microsize for short diffusion distance and delivery of fresh solution by flow for fast 
adsorption. Therefore, it can be applied in bioassay and chemical analysis. 
2.2. Basic principle of immunoassay in MCP 
2.2.1. Size-effect for Immunoassay 
Various materials have been exploited in immunoassays, one of the aims is to speed 
assay. In view of this, the dimension of the reaction chamber plays an important role. The 
decrease of dimension from macro size to micro size will greatly decrease the diffusion 
distance. Consequently, diffusion time will also be dramatically decreased because of the 
proportional of diffusion time to the square of diffusion distance. As shown in Fig. 2-1, it 
illustrated the comparison of diffusion among three kinds of space used for immunoassay. 
Diffusion is the movement of molecules from a higher concentration to a lower one. 
Diffusion distances (d1, d2 and d3) between antigen in solution and the immobilized 
antibody are size dependent. Compared to the conventional microplate, capillary-based 
method shows advantages due to the size decreasing from mm to μm. Besides, 
flow-based immunoassay can be carried out with advantages of fast analysis, less 
sample/reagent consumption and high sensitivity. The decreased microdimension will 
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greatly enhance the reaction efficiency due to the fast diffusion. Undoubtedly, MCP with 
uniformly arrayed microchannel affords a vast of merits compared to single capillary. It 
not only provides a very short diffusion distance, but also a large surface area because of 
the compact microchannels. Therefore, the characteristics of MCP will supply benefits of 
small size, high surface-to-volume ratio, fast diffusion, easy flow handling, high 
integration and high throughput detection for immunoassay. 
 
Fig.2-1. Comparison of diffusion distances (d1, d2, d3) from bulk solution to the wall 
surface of 96-well plate (a); traditional glass capillary (b) and integrated multi-capillary 
glass plate (c). 
2.2.2. Principle of immunoassay in MCP with flow 
Fig. 2-2(a) illustrated the side view of the MCP used in the experiment. It was 
uniformly arrayed with microchannels (20 μm i.d.) at regular intervals, while the distance 
between two neighbouring holes (micro channels) was 5 μm. Fig. 2-2(b) showed the 
appearance of MCP characterized by Keyence VE-8000 scanning electron microscopy 
(SEM). Compared to the working area of conventional 96-well plate performing 100 μL 
liquid, the effective surface area of each reaction chamber (i.d. 4 mm) consisted by MCP, 
is 16 times larger than a single well of 96-well plate, which indicates more protein could 
be immobilized for higher measurement capacity. On the other hand, the ratio of surface 
area-to-volume of microfluidic chamber is approximate 233-fold larger than each well of 
7mm 1mm
d1=3.5mm
7
cm
d2=0.5mm
1mm
4mm
d3=0.01 mm
(a) (b) (c)
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96-well plate. Thus, the MCP constructed microfluidic chamber array has the potential to 
carry out ELISA at high efficiency in compact space because of the enlarged working 
surface for protein immobilization. Meanwhile, the short diffusion distance in capillary 
channels would benefit the fast diffusion for ELISA reaction based on the following 
Formula 1.
 
 
d
2
 = 4Dt                              (1) 
Generally, diffusion is the movement of molecules driven by the concentration 
gradient. Where, d is the average diffusion distance; t is the diffusion time; D is the 
molecular diffusion coefficient. In the case of multicapillary glass plate used in the 
experiment, the diffusion time of protein molecule from the center to the inner wall of 
capillary was less than 0.5 s (considering the diffusion coefficient of protein in water is 5 
× 10
-7
 cm
2
s
-1
 at RT). With a reduction in size from macro to micro dimensional, the 
effects of diffusion became a dominant transport mechanism. Therefore, it was not the 
limiting factor in microchannels since the protein molecules reached the inner surface at 
a much higher rate than their adsorption procedure. It suggested that the diffusion of the 
protein molecules in multi-capillary was almost negligible in the ELISA compared to the 
incubation time (several or tens of minutes) in this experiment, which is the main factor 
need to be considered in traditional 96-well plate.  
Theoretically, the effective diffusion of protein molecules from the center to the 
inner wall of capillary will be influenced by the volume flow rate of the introduced 
solutions as shown in Fig. 2-2c. Considering 0.5 s of the diffusion time of the protein 
molecules from the center to the inner wall in the capillary channel, we calculated the 
feasible volume flow rate of introduced protein solution ensure the sufficient diffusion of 
the protein molecules in capillary. The theoretical value of the volume flow rate 
guaranteeing the sufficient diffusion is no more than 60 μL/min. Therefore, we adopted 
25 μL min-1 of volume flow rate in the whole experiment.  
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Fig. 2-2. (a) Schematic side view of MCP. (b) SEM image of multicapillary glass plate. 
(c) Illustration of the immunoassay performed in the microchannels of the MCP.  
2.2.3. Diffusion and reaction in microchannels of MCP 
While a fast immunoassay basically relies on the antigen diffusion from bulk 
solution to the solid surface immobilized antibody, thus a reduction in size has 
significantly effects on the diffusion distance. Upon the static adsorption of protein onto 
the glass surface, the depletion of the analytes near the capillary surface will decrease, 
which drives the diffusion of molecules from the bulk solution. Due to the relative fast 
molecular diffusion in microdimensions, the depletion will also occur in the bulk solution. 
While when the system combined with microfluidic technique, the solutions can be 
constantly refreshed by delivering fresh solution, which will influence the rate of 
adsorption. Therefore, the rate of adsorption in dynamic condition is always higher than 
the static system at the same time slice. 
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Fig.2-3. Molecule diffusion and reaction in flow-channel of MCP.  
Based on the foregoing discussion of diffusion time, another parameter in the flow 
based immunoassay system should be considered well, that is flow time of molecules 
from inlet to outlet of the microchannel. As is shown in Fig. 2-3, it illustrated diffusion 
and Ab-Ag reaction in a microchannel. Since solutions flowing through the microchannel, 
protein molecules diffused to the innersurface of the microchannel with the moving. For 
the efficient immunoassay, proteins should be captured before moving out of the 
microchannel, which means the flow rate of solutions would be not so much higher. In 
fact, the flow time (t2) would be better not more than diffusion time (t1). According to the 
calculation based on the relationship of flow rate (V) to flow time in 1mm length with 1 
mm
2
 area, the calculated results are list in Table 2-1. 
Table 2-1. Effects of flow rate on flow time 
Flow rate  v (μL/min) 5  10 15 20 25 30 
Flow time t2  (s) 6 3 2 1.5 1.2 1 
1mm
V
t1
t2
Depletion
d
capture antibody
antigen
detection antibody
V
t1
t2
flow rate
d diffusion distance
diffusion time
flow time
40 
 
2.3. Design of the system 
2.3.1. Design and fabrication of microfluidic chamber 
In the design of microfluidic chamber, the MCP was sandwiched by two pieces of 
PDMS slides with uniformly concave and cyclindrical wells as shown in Fig. 2-4a. 
Primary, a photomask for circular well array (8 × 9 wells, 4 mm in diameter.) was 
designed by Adobe Illustrator CS4. And the PDMS slides with wells were fabricated by 
the soft photolithography techniques. Briefly, a piece of cleaned glass (62 × 62 mm) was 
first spin-coated with a layer of negative photoresist (SU-8, 3050), then exposed in the 
UV light through the photomask. Next, it was developed by the SU-8 developer to 
generate a convex and cylindrical array (~100 μm in height, 4 mm in diameter) on glass 
sheet, which was the template for PDMS slides. PDMS prepolymer and curing agent 
were mixed at the mass ratio of 17:1 and poured on the template after vacuum degassing. 
Then the PDMS mixture on the template was cured at 65 °C for 1.5 h. After peeling the 
PDMS slides from the glass template, each concave cylindrical well on the PDMS slide 
was punched with holes in the center to match the PTFE tubing for liquid delivery. The 
microfluidic chamber was constructed by perpendicularly attaching the PDMS slides 
onto the two sides of the MCP, as shown in Fig. 2-4b and 2-4c. Finally, PTFE tubes with 
different inner diameters (1.35 mm for inlet and 0.25 mm for outlet) were inserted in the 
concave well to deliver solutions/buffers (Fig. 2-4d).  
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Fig. 2-4. Schematic design of the microdevice. (a) Construction of the microfluidic 
chamber array with 8 × 9 wells constructed with MCP and two pieces of PDMS slides; (b) 
Photograph of the fabricated chamber array; (c) Sketch of each chamber; (d) 
Cross-sectional view of the chamber.  
2.3.2. Set-up for immunoassay with flow injection 
In the ELISA performance, the PTFE tubing and a 4-port valve were used to 
deliver/switch the buffers/solutions in and out of chamber. The set-up of the microfluidic 
chamber array system for ELISA was schematically shown in Fig. 2-5. One syringe 
drove by pump was used to deliver carrier/washing buffer; while another micro syringe 
(SEG, Australia) was used to load the immune solutions or samples. The 4-port valve 
could switch the liquid (buffer, sample or substrate) to delivery into microfluidic chamber. 
The close sectional view of the injection port structure was schematically shown in the 
enlarged drawing. The MCP assembled chamber was the reaction place for immunoassay, 
while each microchannels in the chamber was a micro-reactor with down-scaled 
diffusion size. The final fluorescent product was collected into the wells of a 96-well 
plate to measure the fluorescent intensity. Additionally, the MCP and the PDMS slides 
both could be reused after thoroughly cleaning and rinsing. 
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Fig. 2-5. Experimental setup for ELISA consisted of MCP reaction chamber system 
2.4. Comparison and conclusion 
The design of MCP based 3D microarray predominates in the performance of 
immunoassay compared to the traditional 96-well plate and a single capillary or 
microchannel. Because of the high cooperation with parallel detection and microsize 
effection, also with the microfluidic technique, the powerful system will supply various 
functions. It shows great advantages over the traditional 96-well plate method. As can be 
seen from Table 2-2, there are some physical factors demonstrate the superior 
improvements in view of sample consumption, assay speed and device size. Obviously, 
MCP-based system can decrease assay time from hours to minutes benefited from the 
very small diffusion distance. Additionally, cost will be cut with low consumption of 
sample/reagent, especially for bioassay. 
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Table 2-2. Comparison between MCP-based method and the 96-well plate method 
Factor 96-well plate method MCP-based method 
Diffusion distance cm µm 
Reagents volume hundreds of µL tens of µL 
Assay time hours minutes 
System bulk tens of cm few of cm 
 In conclusion, MCP can be integrated with PDMS to construct microarray for 
ELISAs with flow system. Due to the compact microchannels, various merits afford a 
powerful system in combination with the traditional advantages of 96-well plate and the 
current popular microfluidic technique. The device based technique could be used in 
disease diagnostic and medical study with fast, sensitivity and high throughput analysis 
in future. 
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Chapter 3. Validation of the MCP-based system and comparison to 
the 96-well plate 
Abstract 
A novel and accelerated enzyme-linked immunosorbent assay (ELISA) was 
developed with the MCP-assembled microfluidic chambers. The device was constructed 
by MCP sandwiched with two pieces of well-fabricated PDMS slides with holes for 
solution entry and exit. The biological recognition took place on the inner surface of the 
microchannels to realize the principle of microanalysis with normal scale sample amount. 
In addition, the effective surface area available for proteins immobilization was increased 
largely, compared to a planar substrate or a single glass capillary. The designed 
microfluidic device was used to detect human IgA in human reference serum. Optimal 
conditions for the sandwich immunoassay were investigated. The limit of detection (LOD) 
for human IgA was achieved at 97.2 pg/ mL, and the analysis time was also shortened to 
less than 1.0 hour. Thus, the present ELISA platform is expected to speed up disease 
diagnosis, and to act as the prompt clinical tool in the future. 
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3.1. Introduction  
The development of ELISA is of great interest and significance in the food analysis, 
disease diagnosis and environmental monitoring. It has increased dramatically and gained 
popularity in the clinical applications because of its high sensitivity and selectivity [1].
 
Typically, the ELISA is commonly carried out in a 96-well plate, which requires 
sub-milliliters of sample and reagents, also long analysis time from several hours to 2 days. 
For these reasons, the development of novel ELISA technologies for rapid immunoassay 
is of great importance. Thus, many researches are devoted to the improvement of the 
ELISA performance. Some are based on the modification of 96-well plate [2] or 
miniaturization of the 96-well system [3] to improve the performance in terms of speed 
and simplicity. Others are based on the application of microbeads [4-6] with large surface 
areas to enhance the sensitivity.  
Microstructures in micro or nano dimension with large surface to volume ratio have 
gained a great deal of attention in analytical and biochemical research. It not only brings 
rapid and sensitive analysis due to short diffusion distance, but also leads to low 
sample/reagents consumption owing to the small reaction space. Microfluidic chip is 
emerging as a powerful platform which benefits from high integration and throughput 
assay with the advantages of low cost, rapid and multiplex analysis [7]. Recently, 
microfluidic platform was also developed in ELISA to minimize immunoassay system 
with lower sample/reagents consumption and easy performance. Roda et al. [8] fabricated 
a microfluidics-based reaction chip for different types of bioassays in personalized 
diagnostics. Ikami et al. [9] reported a special microchannel integrated with immune pillar 
to perform fast multiplex immunoassay, which embodied multiple antibody immobilized 
polystyrene (PS) beads into the polyethylene glycol (PEG) matrix. In these 
microfluidic-based ELISA, large surface-to-volume ratio of microchannels is beneficial to 
shorten diffusion length for fast immunoreaction and to improve the antigen-antibody 
recognition for high detection sensitivity.  
In the past decade, glass capillary was also utilized in ELISA because of its small 
scale and high surface-to-volume ratio resulted in low sample consumption and fast assay. 
For example, Henares et al. [10]
 
presented a single-step immune-sensor in a single square 
capillary to achieve the quick ELISA, which combined with surface-bonded glucose 
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oxidase, antibody and physically adsorbed PEG membrane containing peroxidase-labeled 
antibody. Yacoub-George et al. [11] developed an immune-detector by using 10 
fused-silica capillaries arranged in parallel, which were coated with selected capture 
antibodies for biological immunoassay. Typical immunoassay process involved many 
steps, such as sample and reagent introductions, incubations and frequent washings. 
Simplifying the procedures of immunoassay and shortening the assay time would enable 
the system to carry out on-site diagnosis. These approaches sometimes combined with 
flow through injection or microfluidic techniques aiming at superior assay performance. 
However, the limited working area and surface area-to-volume ratio with single channel 
restricted the reaction efficiency and sensitivity.  
Interestingly, MCP, with microchannels oriented in parallel, can be applied to be the 
solid matrix in immunoassay and easily meet the requirements of flow system. Actually, 
MCP exhibited great bio-compatibility and significant merits in biochemical analyses. 
Benoit et al. [12] presented a methodology for the multiplexed nucleic acid hybridization 
fluorescence assay on multicapillary glass substrates, which shown the optical properties 
of the MCP and improved the performance of hybridization assay based on the use of 
three-dimensional multicapillary glass biochip. Another work was reported by 
Betanzos-Cabrera et al., [13] they developed a MCP-based method for distinguishing a 
new class of human short insertion/deletion polymorphisms by tandem hybridization. 
Although the approaches took advantage of flow through system, the MCP-based flow 
chamber was fabricated into a sealed gasket with special designed devices. While, 
microfluidic-based system combined with MCP is expected to be attractive in 
immunoassay, which has potentials to simplify and shorten the ELISAs procedures 
besides high sensitivity compared to the traditional 96-well microplate technique or a 
single immunochannel assay. Because of the enhanced surface area-to-volume ratio of 
multicapillary and the scale-reduced microchannels, the Ab-Ag reaction will be 
accelerated with high sensitivity. Thus, the immunoassay utilized MCP can obtain high 
efficiency and decrease the consumption of reagents and sample. 
In this chapter, a microfluidic chamber consisted of MCP was developed for fast 
ELISA, and was used to perform the measurement of human IgA. Coating antibody was 
captured onto the inner-surface of MCP by physical adsorption, which had already been 
studied and applied in immunoassay [14,15]. Flow-handling technique made performance 
easier by the connection of microfluidic chamber to the upper and lower PDMS layers for 
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liquid entry and exit. Thus, the present method simplified the practical procedures of 
ELISA to lower assay time and improved the sensitivity with small sample consumption. 
We expected the present MCP assembled microfluidic chamber array could be adapted to 
the high-throughput and rapid analysis of biomarkers and the on-site diagnosis of diseases. 
3.2. Experimental  
3.2.1. Reagents and materials 
Affinity purified goat anti-human IgA, Human reference serum and HRP conjugated 
goat anti-human IgA were obtained from Bethyl Laboratories (Montgomery, USA). 
Bovine serum albumin (BSA) was obtained from Merck (Calbiochem, German). 
10-acetyl-3, 7-dihydroxyphenoxazine (Amplex
®
 Red) was purchased from Life 
technology Japan (Tokyo, Japan). It was dissolved in dimethylsulfoxide (DMSO) at 13.8 
mmol/L and stored in -20 °C before use. The Amplex
®
 Red substrate solution was 
prepared when used, by mixing 0.01 mL of above Amplex
®
 Red stock solution with 0.94 
mL of 100 mmol/L phosphate-buffered saline (PBS) buffer (pH=7.4) and 0.05 mL of 20 
mmol/L H2O2 solution. Na2HPO4, NaH2PO4 and H2O2 were purchased from Wako Pure 
Chemical Industries (Osaka, Japan). 100 mmo/L PBS buffer (pH=7.4) was prepared from 
100 mmo/L Na2HPO4 and 100 mmol/L NaH2PO4. Washing buffer (PBST) was prepared 
with 0.5% (w/v) BSA /0.1% (v/v) Tween-20 in 100 mmol/L PBS (pH=7.4). 100 mmol/L 
NaOH (Kanto Chemical Company, Tokyo, Japan) was prepared for the activation of 
multicapillary glass plate. The 10 μg/mL of human IgA stock solution was obtained by 
diluting the primary human reference serum in 100 mmol/L PBS buffer (pH = 7.4), and 
the standard solutions were prepared by further diluting the human IgA stock solution 
with 100 mmol/L
 
PBS buffer. All the solutions and buffers were prepared with deionized 
water purified by Milli-Q system from Nihon Millipore (Tokyo, Japan). All buffers used 
in the experiment were filtered through a 0.45 μm membrane filter (Jhwpo 4700, Nihon 
Millipore, Tokyo, Japan). The neutral detergent used for multicapillary glass plate 
cleaning was obtained from Tomisc company (Tokyo, Japan), and acetone was from 
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Kanto Chemical Co. Inc., (Tokyo, Japan). The PDMS kit was obtained from Dow 
Corning Toray (Tokyo, Japan). MCP (type J-5022-19, 55% open area ratio, 1mm in 
thickness, effective area 53 × 53 mm, capillary i.d. 20 µm) was obtained from 
Hamamatsu Photonics (Hamamatsu, Japan). The 1000 μL gastight syringe from 
Hamilton (Reno, NV, USA) was used to introduce the carrier buffer. The PTFE tubes 
obtained from Chukoh Chemical Industry, Ltd. (Tokyo, Japan) were used to connect the 
syringe and the chambers for solutions/buffers delivery. A Harvard PHD 2000 syringe 
pump from Harvard Apparatus (Holliston, MA) was employed to deliver all solutions to 
the reaction chambers. A Branson 5210 ultrasonic cleaner (Yamato Industry, Tokyo, 
Japan) was used for the cleaning of MCP and an Espec ST-110 high temper oven (Osaka, 
Japan) was used for PDMS thermo-curing. A 96-well microplate reader from Tecan Japan 
(Kawasaki, Japan) was used to measure fluorescence intensities. 
 
3.2.2 Immunoassays 
A sandwich immunoassay for human IgA measurement was carried out by using the 
presented microfluidic chamber system described in 2.2.2 at RT. Preliminarily, the 
microfluidic chamber was rinsed with 1 mL of 10 mmol/L PBS buffer (pH=7.4). Then, 
15 μL of 50 µg/ml goat anti-human IgA was loaded into the chamber through PTFE 
tubing by carrier buffer (PBST). Consequently, the syringe pump was stopped to let 
solution keep in the chamber for 10 min for incubation, and un-immobilized goat 
anti-human IgA would be flushed out by PBST buffer for 3 min at the flow rate of 25 
μL/min. Then, 15 μL of 3% (w/v) BSA in 0.1 mol/L PBS buffer was introduced into the 
chamber and kept for 10 min for incubation. After rinsed with PBST buffer for 3 min at 
25 μL/min, diluted human reference serum containing human IgA concentrations in the 
range of 0.01 ng/mL to 1000 ng/mL was delivered into the chamber for antigen capture. 
Followed by 10 min incubation, the unbound human IgA were washed out by 25 μL/min 
PBST buffer for 3 min. Then 15 μL of 5 μg/mL HRP-conjugated goat anti-human IgA 
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was loaded into the microfluidics chamber, and stopped for 10 min incubation. And the 
un-reacted capture antibody was flushed out of the chamber by PBST buffer for 5 min at 
25 μL/min. Finally, the new prepared solution of Amplex® Red combined with H2O2 was 
delivered into the chamber to generate optically measurable fluorescent resorufin. The 
final fluorescent products were collected into the well of 96-well plate and measured by 
the microplate reader (Ex/Em = 570 nm/590 nm). 
3.3. Results and discussion 
3.3.1. Effect of flow rate to the reaction efficiency in microchamber 
In this work, a flow chamber was designed for immunoassay, Ab-Ag reaction is 
occurring in the microchannels. While, in the microchannel, chemical reactions are high 
efficient due to the significant effect of channel size. In order to investigate the effect of 
flow rate to detection efficiency, a plot of substrate flow rate to signal intensity was made, 
as shown in Fig. 3.1. Here, the signal intensity was recorded by the reaction of Amplex 
Red and HRP-conjugated second antibody in the presence of H2O2, in which a 
fluorescent product of Resorufin was generated. Experimentally, after the second 
antibody was immobilized onto the inner surface of microchannels in the reaction 
chamber, the substrate solution with H2O2 was flowed through the chamber at different 
flow rate. With enzyme-catalyzed reaction, the products were generated and driven out. It 
was then collected for fluorescence measurement by 96-well plate reader. The results 
showed that the higher flow rate led to decrease of signal intensity due to the unefficient 
reaction between substrate molecular and the coated antibody. While, a better signal 
response was obtained when the flow rate was set at 15 μL/min. Additionally, the flow 
time for molecular from the inlet of channel to outlet was 2s, while the diffusion time 
from center to the surface could be calculated to 1s. Which demonstrated the flow 
through reaction was enough for molecules diffused to the surface for reaction before 
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driven out of the chamber. Thus, 15μL/min was used for substrate introduction in the 
following experiments. 
 
Fig.3-1. The effect from the flow rate to the reaction in the micro-channel. 
3.3.2. Capacity of protein adsorption 
The capacity of the device for proteins adsorption is of vital importance in 
immunoassay. The interactions between protein and surface are influenced by the 
properties of proteins, the solid surface, ambient conditions and so on [19]
 
To investigate 
the capacity of proteins adsorption on the MCP, the adsorption amount of the second 
antibody of HRP conjugated goat anti-human IgA was measured as Fig.3-2 shown. The 
amount of protein added was calculated based on the concentration and volume, 15 μL of 
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solution with the concentration range from 0.001 μg/mL to 100 μg/mL was loaded into 
the chamber and stopped for 5 min for incubation. Followed by 5 min washing with 
PBST at the flow rate of 25 μL/min, substrate of Amplex® Red was introduced to 
generate the photic detectable Resorufin product. The amount of adsorbed protein was 
calculated based on the measured fluorescence intensity. Seen from the black line with 
square marks, the signal increased greatly since it came to 1 μg/mL, while the increase 
slowed down from 10 μg/mL. The adsorption was not saturated at concentration as high 
as 100 μg/mL. Meanwhile, a comparative experiment of the adsorption capability using 
PDMS chamber without MCP was also carried out. The adsorption capability of PDMS 
for the HRP conjugated goat anti-human IgA was obvious dropped down as shown in 
Fig.3-2 (the red line with dot marks). It indicated that the proteins adsorption was mainly 
devoted by the MCP instead of the PDMS slide in microfluidic chamber, which would be 
the main role in the following ELISA assay. The results might come from the large 
surface area of the multi microchannels for higher absolute binding. On the other hand, 
the enhanced surface area-to-volume ratio was likely leading to the higher bound fraction 
and the binding kinetics in the microchannel significantly different with fast diffusion. 
 
Fig.3-2. Comparative investigations of proteins adsorption capacity in the developed 
microfluidic chamber between with and without MCP. Three layers chamber with MCP 
(black line with square marks) and the PDMS slides constructed chamber (red line with 
dot marks).  
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3.3.3. Effect of incubation time  
An important procedure in the sandwich ELISAs was the immobilization of the 
capture antibody onto the solid surface. Besides the effect coming from the sufficient 
diffusion of protein molecules in the microchannel, the enough incubation was also vital 
to efficient coating capture antibody and conjugation of antibody-antigen in ELISA 
assay. In the experiment, the incubation time/stop time for the efficient antibody-antigen 
interaction was investigated at the scope of 0 - 20 min as shown in Fig.3-3. The antigen 
and antibody solutions were all orderly loaded into the microfluidic chamber follow the 
above ELISA procedure, and kept in the microfluidic chamber for incubation at 
different durations. We can see from the results, the fluorescence intensity was enhanced 
with the increasing incubation time and it became placid until 10 min of the incubation 
time. Compared to the traditional 96-well plate method with 30 min or long time for 
incubation, the present approach could greatly decrease the assay time in the sandwich 
immunoassay. 10 min was determined to be the practical incubation time for the ELISA 
assay in the following experiment. 
 
Fig.3-3. Effects of incubation time for the immunoassay performed in the microfluidic 
chamber. The measurements were performed under 225 ng/mL of Human IgA. 
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3.3.4. Quantitative immunoassay 
In this paper, human IgA in human reference serum was determined by the 
developed method with the MCP consisted microfluidic device, the quantitative curve 
was constructed through measuring the fluorescent intensity produced by the sandwich 
immunoassay with different concentration of human IgA. Fig.3-4 illustrated the 
calibration curve of the human IgA. The lowest concentration tested and detected was 
0.01 ng/mL. By using the microfluidic chamber system, the analytical sensitivity of 97.2 
pg/mL was obtained (It was calculated by the average fluorescence intensity of the blank 
plus 3 times of standard derivation of blank (SDblank). The error bar was calculated from 
five repeated measurements performed at different days using recycled microfluidic 
chamber. It indicated the MCP-based immunoassay system can be recycled and applied 
to perform a quantitative immunoassay.  
 
Fig.3-4. Calibration curve for the measurement of human IgA performed in the 
MCP-assembled microfluidic chamber. All the immunoassay solutions and samples were 
stopped in the chamber for 10 min incubation at room temperature, and washed for 3 min 
(except second antibody for 5 min) at the flow rate of 25 μL/min. 
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3.3.5. Comparisons between the microarray system and the 96-well 
plate method 
And the same measurement was carried out on the 96-well plate to be a reference. 
Table 3-1 gave a comparison between the MCP consisted device and the conventional 
96-well plate in the measurement of human IgA. The results showed the reagents 
consumption in presented microfluidic chamber was greatly decreased because of the 
downscaled microstructure. The total assay time was also evidently reduced by taking 
advantage of microfluidic chamber system, which was attributed by the fast diffusion in 
capillaries. 
Table 3-1. Comparison of the sandwich ELISAs performed in the microfluidic chamber 
system and the conventional 96-well plate. 
Assay solution and 
parameters 
The microfluidic chamber 
system 
 Conventional 96-well 
plate 
Volume / 
step (μL) 
Duration 
time (min) 
 Volume / 
well (μL) 
Duration 
time (min) 
Coating antibody 15 10  100 60 
Washing buffer 75 3  300×5 10 
Blocking buffer 15 10  200 30 
Washing buffer 75 3  300×5 10 
Antigen 15 10  100 60 
Washing buffer 75 3  300×5 10 
HRP-conjugated antibody 15 10  100 60 
Washing buffer 75 5  300×5 10 
Substrate 50 2  100 15 
Total assay volume/ time 410          56  6600         265 
LOD (pg mL
-1
) 97.2  625 
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3.4. Conclusions 
In this study, a MCP as solid matrix combined with PDMS slides was used to 
construct the reaction chamber for ELISA, which could greatly increase the surface area 
for protein adsorption and decrease diffusion time of protein molecules in solution. The 
microfluidic chamber immunoassay afforded the rapid assay simplified the tedious 
introducing and washing steps in traditional ELISA in 96-well plate. The experimental 
data demonstrated the assay time, reagents consumption were both tremendously 
decreased, while, the lower limit of detection (LOD) of h-IgA measurement was obtained 
comparing to the traditional 96–well plate method (625 pg/mL). We believe the presented 
method will be the perspective research for the speedy and compact ELISA device, which 
is easy to be fabricated and used in food safety, environmental monitoring and clinical 
diagnosis.    
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Chapter 4. Compact Immunoassay Platform based on a 
Multicapillary Glass Plate 
Abstract  
A highly sensitive, rapid immunoassay in multi-channels of a micro-well array 
consisting of a multicapillary glass plate (MCP) and polydimethylsiloxane (PDMS) slide 
is described. The micro-dimension and large surface area of the MCP permitted the 
diffusion distance to be decreased and the reaction efficiency to be increased. To confirm 
the concept of the method, human immunoglobulin A (h-IgA) was measured using both 
the present immunoassay system and the traditional 96-well plate method. The proposed 
method decreased to a 1/5 fold of immunoassay time, and cut to a 1/56 fold in reagent 
consumption with a 0.05 ng/mL
 
of Limit of detection (LOD) for IgA. The method was 
also applied to saliva samples obtained from healthy volunteers. The results were well 
correlated to those by the 96-well plate method. The method has the potential for use in 
automated, on-site immunoassays. 
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4.1. Introduction 
The development of simple, rapid immunoassay approaches is of tremendous 
importance for on-site diagnostics and for monitoring highly infectious diseases [1]. 
Infectious diseases, such as the avian influenza virus, severe acute respiratory syndrome 
(SARS), hand-foot-and-mouth disease, influenza H1N1 and H7N9 are all threats to 
human health/life and collectively cause losses to social/economic development [2,3]. 
Therefore, developing methods for the rapid on site assay of these diseases at an early 
stage is extremely important. The enzyme-linked immunosorbent assay (ELISA) is one 
of the most widely used approaches in clinical diagnostics, food safety testing, and 
environmental monitoring [4,5]. The technique is usually carried out in a 96-well 
microtiter plate and involves a series of tedious processes, including sample introduction, 
incubation and washing. Moreover, substantial amounts of sample are consumed and the 
method is time-consuming, and sometimes suffers from low sensitivity [6]. In order to 
overcome these drawbacks, various efforts have been devoted to developing new 
methods for diagnostic immunoassays. For example, ELISAs have been integrated with a 
micro/nano system to increase the surface/volume ratio and improve reaction kinetics 
[7-9].
 
 A variety of materials, such as quantum dots [10],
 
photonic crystal [11], 
membrane [12] or papers [13], have also been used in conjunction with immunoassays.  
On the other hand, the microfluidic technique, with its advantages of miniaturization 
and integration has also been widely exploited for use in immunoassays [14].
 
However, 
in the microfluidic-based immunoassay, a single microchannel is always used as the 
working space for an immunoassay
 
[15] and has the limitation of a small working surface. 
Similarly, a glass plate or glass capillary, which has also been exploited for use in 
immunoassays [16,17] also has limitations in that a flat surface or a single channel is 
used. Interestingly, a MCP with uniformly paralleled microchannels would be an ideal 
candidate for use in an immunoassay. Such a material has been used for DNA 
hybridization reactions [18], in which MCP showed substantial advantages over flat glass, 
in terms of its higher sensitivity and a faster hybridization rate. We previously reported 
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on the use of MCP combined with a microbead-based chemiluminescence immunoassay 
[19], in which it simply acted as a switch for bonding/free protein separation. However, 
the use of the inner surface of the MCP to increase the immobilization capacity of an 
antibody to improve the reaction efficiency of an immunoassay does not appear to have 
been utilized.  
We report herein on the development of a compact immunoassay utilizing 
microchannels within the MCP, which has a large surface area and high surface-to-volume. 
Thus, the MCP ratio could not only increase coating capacity, but also accelerate an assay. 
The method would be expected to decrease overall immunoassay time because of the short 
diffusion distance in the microchannels of the MCP. The compact immunoassay system 
shows considerable potential in terms of speed and high-sensitivity for on-site diagnosis 
and for rapidly monitoring a disease. 
4.2. Experimental 
4.2.1. Reagents and apparatus  
   A human IgA kit, including affinity purified goat anti-human IgA (1st Ab), a human 
reference serum solution and goat anti-human IgA HRP conjugated (2
nd
 Ab), was obtained 
from Bethyl Laboratories (Montgomery, USA). Bovine serum albumin (BSA) was 
obtained from Merck (Calbiochem, German). 10-acetyl-3,7-dihydroxyphenoxazine 
(Amplex
®
 Red reagent) was purchased from Life technology of Invitrogen (Eugene, USA). 
It was dissolved in dimethylsulfoxide (DMSO) to a concentration of 13.8 mmol/L for use 
as a storage solution and was stored in refrigerator at -20 °C prior to use. The working 
substrate solution of Amplex
®
 Red was prepared by mixing with phosphate-buffered 
saline (PBS) buffer (pH=7.4) and H2O2 solution just before use. Na2HPO4, NaH2PO4 and 
H2O2 were purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Washing 
buffer (PBST) was prepared with 0.5% (w/v) BSA/0.1% (v/v) Tween-20 (Kanto Chemical 
Co., Inc., Tokyo, Japan) in 100 mmol/L PBS (pH=7.4). 10 mmol/L
 
NaOH (Kanto 
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Chemical Co., Inc., Tokyo, Japan) and 10 mmol/L
 
HCl (Wako Pure Chemical Industries 
Ltd. (Osaka, Japan) were prepared for the cleaning of the MCP. All solutions and buffers 
were prepared with deionized water purified by Milli-Q system from Nihon Millipore 
(Tokyo, Japan). All buffers used in the experiments were filtered through 0.45 μm 
membrane filter (Jhwpo 4700, Nihon Millipore, Tokyo, Japan). A neutral detergent 
(TCN-5) used for plate cleaning was obtained from Tomisc Company (Tokyo, Japan) 
A polydimethylsiloxane (PDMS) kit (Silpot 184) was obtained from Dow Corning 
Toray (Tokyo, Japan). MCP (1mm in thickness, effective area 20 × 20 mm, capillary i.d. 
20 µm) was obtained from the Incom Company (Charlton, USA). A Branson 5210 
ultrasonic cleaner was obtained from Yamato Industry (Tokyo, Japan).  A 96-well plate 
reader (SpectraFluor Plus) was obtained from Tecan (Melbourne, Australia). An Espec 
ST-110 high temperature oven (Osaka, Japan) was used for the PDMS thermo-curing. An 
incubator (SN-M 40S, Japan) was obtained from the Nissin Co. 
 4.2.2. Setup 
Fig. 4-1a schematically illustrates the setup used for the microwell device and the 
system construction. The microwell immune device was composed of a MCP and a 
PDMS slide. The PDMS slide with a 5×5 hole-array (Φ =2 mm for each hole) was 
reversibly attached to the surface of the MCP to produce a 5×5 well array. The device 
was placed onto a laboratory-made holder combined with an electromotive x-y stage for 
movement to the detection point. Measurements were carried out by an incident light 
fluorescence microscope (BX-51, Olympus, Tokyo, Japan) system equipped with filter 
set XF-102 (for Resorufin, Opto Science, Inc.) integrated with a 543.5 nm laser (3478EC, 
Melles Griot, Carlsbad, California, USA). The fluorescence signal was detected by a 
photomultiplier (PMT) (H7422-40, Hamamatsu Photonics, Japan), and the signal was 
amplified by means of a laboratory-made current amplifier, the magnified analog signal 
was then converted to digital data by a 12-bit A/D converter (PicoScope 4224, Pico 
Technology, Cambridgeshire, UK) and recorded with a PC (Dell Inc., DCNE, China). Fig. 
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4-1b shows a cross-sectional view of a microwell consisting of the MCP and PDMS slide. 
The antibody/antigen recognition reaction took place in the compact microchannels in 
the MCP, and each microchannel acts as a micro reactor, as shown in Fig. 4-1c. 
4.2.3. Fabrication of the MCP assembled micro device 
A PDMS slide was prepared by mixing the PDMS prepolymer and curing 
crosslinker at a mass ratio of 18:1 and the resulting mixture was degassed in vacuo. The 
mixture was then poured onto a cleaned glass, which was fenced with scotch tape, 
followed by curing at 65 ºC for 1h. The PDMS slide was sequentially peeled off and 
drilled with a punch (2 mm diameter) for each well to form a 5×5 microarray (20 mm × 
20 mm). The PDMS slide was immersed into a 50% ethanol solution and then deionized 
water for ultrasonic cleaning for 30 min, respectively. After cleaning, it was dried at 80 
ºC for 10 min. At the same time, the MCP was successively cleaned with a neutral 
detergent, deionized (DI) water, 0.01 mol/L
 
HCl, DI water, 0.01 mol/L
 
NaOH, DI water. 
It was then dried at 80 ºC for 20 min. Finally, the cleaned MCP and the above cleaned 
PDMS slide were attached to form the microarray (as shown in Fig.4-1), and the 
attachment was reinforced by heating at 80 ºC for 10 min. 
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Fig. 4-1. Schematic diagram of the compact immunoassay in a microwell array on MCP, 
integrated with an x-y stage and a laser-induced fluorescence measurement system (a), 
cross-section of a single microwell consisting of MCP and a PDMS slide (b), and the 
schematical illustration of the compact ELISA performed in microchannels within MCP, 
in which each microchannel with 20 μm diameter is acted as a micro reactor with short 
diffusion distance (c).   
4.2.4. Performance of ELISA 
4.2.4.1. Assay protocol for ELISA using the microarray device  
A sandwich immunoassay was performed to detect h-IgA to confirm the concept of 
the developed compact immunoassay. A coating solution of the 1
st
 Ab was pipetted into 
MCP-constructed microwells at an amount of 2.0 μL/well, followed by incubation in a 
humidity controlled cabinet (RH = 97 ± 5%) at 37 ºC for 30 min. After incubation, waste 
solutions were removed by touching the bottom of the MCP with a filter paper (No.51B, 
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Advantec, Tokyo, Japan). Then, 3.0 μL/well of PBST buffer was introduced into the 
microwells for washing, and the waste solutions were also moved away by touching the 
bottom of the MCP with a filter paper. The washing procedures were performed 3 times. 
A BSA (1%, w/v) solution was next introduced into each microwell with 2.5 μL/well for 
blocking. After 30 min incubation in a 97% RH cabinet at 37 ºC and 3 washings with 
PBST buffer with 3.0 μL/well, different concentrations of h-IgA solutions were 
introduced into each microwell.  
After a 10 min incubation in the 97% RH cabinet at 37 ºC, each microwell was 
washed 3 times with PBST buffer. The 2
nd
 Ab solution was then introduced into 
microwells at a volume of 2 μl/well. After a 10 min incubation, the unabsorbed 
antibodies were removed by washing 5 times with PBST buffer. Finally, 2.5 μL/well of 
an Amplex
®
 Red substrate solution (6.9mmol/L Amplex
®
 Red, 50 mmol/L H2O2, 
100mmol/L PBS) was pipetted into each well to generate Resorufin for fluorescence 
detection.  
4.2.4.2. Saliva sample measurement 
Saliva samples were collected from 6 healthy volunteers at around 10:30 in the 
morning and were placed in polypropylene tubes (15 mL). The samples were centrifuged 
at 10000 rpm for 30 min. The supernatant was then isolated, and diluted with PBS (0.01 
mol/L, pH 7.4) buffer. Before the ELISA, samples with different dilution factors ranging 
from 10 to 10,000 fold were prepared in PBS buffer and tested. The measurements of 
h-IgA in saliva were carried out using the microwell array following the above ELISA 
procedures. At the same time, the saliva samples were also measured by the 96-well plate 
method using the same dilutions as the reference. 
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4.3. Results and discussion 
4.3.1. Principle of Immunoassay in a MCP Open Chamber and 
Capillary-action 
A MCP was uniformly arrayed with microchannels (20 μm i.d.), and the open ratio of 
the plate was more than 50%, as shown in the scanning transmission electron microscope 
image in Fig.4-2a, the inserted photo. The compact microchannels in the MCP were 
utilized as a solid substrate for an immunoassay to greatly enhance the surface area and 
decrease the diffusion distance. The density of the immobilized antibody could be 
improved by increasing the surface area to achieve a high specific surface area (SSA), and 
the antibody and antigen complex reaction would be accelerated by the short diffusion 
distance [18,21].  Meanwhile, the capillary force driven system appears to be quite 
compatible with flow handling and permits the pumps and valves to be eliminated [22,19]. 
Solution holding was achieved by the capillary force, while solution flow was achieved by 
a filter paper in contact with the bottom of the MCP. In terms of these, procedure of 
multistep immunoassay will be simplified. As shown in Fig.4-2b(i), the solution flows into 
the microchannel with Laplace pressure ( p ) as the driving force [24]. Capillary force 
(Fp) is based upon the tendency of a liquid to minimize its surface area driven by surface 
tension (γ). Due to the adhesive power of the liquid on the inner wall of the microchannel, 
the injected liquid can enter the channels, which can be explained by the Young–Laplace 
equation: 
R
p
 cos2
                              (1) 
Where, γ is the surface tension of liquid, θ is the contact angle, and R is the surface 
curvature radius [25]. The capillary force of Fp is then expressed as 
 cosπ2 RFp                               (2) 
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Initially, Fp was nearly 0 as liquid on the tip of the microchannels. While with the liquid 
moving into the channel due to the wettability of the glass surface, the downward Fp 
gradually increased. Thus the liquid travelled down to the channels driven by capillary 
force and gravity (Fg) [22]. Meanwhile, Fg represents as 
gπ 2hrFg                                 (3) 
Where, ρ is the density of the solution, h is the height of the liquid, r is the radius of the 
channel, and g is the gravity constant. With the moving of the liquid to the bottom of 
microchannel, the meniscus of the curved surface changed from concave to convex 
resulting in the reverse of the capillary force. Thus the value of Fp reversely increased 
compared to gravity force. When the liquid reached the end tip of the microchannel, the 
upward capillary force will approach to the downward gravity force and the liquid will be 
balanced at the point where the two forces are equal, i.e. Fp = Fg. Therefore, the height of 
the liquid can be calculated as 
2g
cos2
r
γR
h


                                  (4) 
The maximum supporting capillary force theoretically occurs at θ=180o (actually the 
contact angle does not change). While the surface curvature radius decreases concomitant 
with the decreases of the liquid surface (see Fig. 4-2b(ii)) till to the radius of the 
microchannel. In the case of water, the minimum height of the liquid is approximately 
1.49 m, which is sufficiently large to hold the liquid in the microchannel (1mm in height). 
Therefore, the solution can be held sufficiently to permit incubation in ELISA at the 
point of equilibrium between Fp and Fg. On the other hand, the solution can be removed 
by a filter paper in contact with the bottom of the microchannel, as shown in Fig. 
4-2b(iii), which disarranged the balance between Fg and Fp and allows the liquid to pass 
through.  
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Fig.4-2. Schematic illustration of MCP based ELISA and capillary force-controlled flow 
system. 
4.3.2. Optimization of detection point 
Laser induced fluorescence (LIF) measurement is one of the most sensitive 
detection techniques for an immunoassay. However, optimization of the detection point 
in the LIF system is extremely important for obtaining reproducible signal recording. 
Consequently, Resorufin which is the product of the reaction of Amplex
®
 Red with H2O2 
catalyzed by HRP was used to investigate the effects of the detection point in the 
microwell. As shown in Fig. 4-3, focusing the point of the laser onto the capillary surface 
was easily accomplished using the microscope. When the focus point was moved 
up/down or away from the MCP surface, the signal response changed accordingly. From 
the results, a slight lifting of the focus point resulted in an improved fluorescence 
recording for both signal intensity and reproducibility due to the increase in the excited 
surface area.   
Capture antibody Antigen
Detection antibody with HRP
Substrate of
Amplex Red
(a) (b)
(i) Introducing
(ii) Incubation
θ1
θ2
Fg
Fp
θ3
(iii) Washing
Fp: Capillary force
Fg: Gravity force
θ : Contact angle
Filter paper
θ4
Fg
Fp
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Fig.4-3. The effect of laser focusing point for fluorescence detection in the microwell was 
investigated by measuring a Resorufin solution (50 μmol/L). The inserted schema 
illustrated focusing point moving up and down vertically to the surface of the MCP.   
4.3.3. MCP-based immunoassay  
In this study, MCP with uniform microchannels (20 μm i.d., 50% open ratio) was 
utilized as the solid matrix for immobilizing the coating antibodies (1
st 
Ab) in ELISA. 
Since the amount of immobilized 1
st
 Ab was the critical parameter that affected the 
capability of catching the target antigen, this is critical in terms of the reaction efficiency 
of an immunoassay. Additionally, the velocity of the reaction controlled by diffusion was 
also greatly decreased due to the small size of the microchannels. As summarized in 
Table 4-1, the valid surface area of the proposed method for the immobilization of
 
coating antibody was about 4 times larger than that of a traditional 96-well plate. 
Moreover, the surface-to-volume ratio was greatly increased, which accelerated the 
antibody-antigen reaction with minimal reagent consumption. Therefore, the MCP-based 
microfluidic chamber array can be used to perform ELISA measurements and is highly 
efficient compared to competing methods.   
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Table 4-1: The physical parameters of microwell array and 96-well plate.  
 Microwell 96 well plate 
Diameter of well /mm 2  7  
Valid surface area /mm
2
 314  76.93 
Volume /μL 1.57  100  
Surface-to-volume ratio 200 0.7693 
Diffusion distance from center/mm  0.01  3.5  
Diffusion time/s 0.5  6.125×10
4
 
The other benefit of the microchannel in MCP was the shortened diffusion distance 
for the interaction of the antibody and antigen [20].
 
As shown in Table 4-1, the diffusion 
length of the antigen (from the center to the inner surface of the microchannel) was 
shortened from 3.5 mm to 0.010 mm for the traditional 96-well plate and the MCP, 
respectively. This results in a tremendous decrease in the diffusion time for the antigen to 
contact the antibody on the surface. Meanwhile, due to the small size of the microchannels, 
the injected liquid entered in the channels driven by capillary force [24]. While with the 
liquid moving into the channel and travelling down to the end tip of the microchannels, 
the upward capillary force holds the water pillar inside the microchannels [21]. Therefore, 
the solution could be held in a stable orientation to permit incubation in ELISA. On the 
other hand, the solution could be easily removed by touching a filter paper to the bottom 
of the MCP, which disrupted the balance between capillary force and gravity force and 
allowed the liquid to pass through the microchannels. By such a performance with liquids 
stop/flow, the washing in ELISA was made extremely simple.   
4.3.4. Optimization of some conditions for h-IgA measurement 
As shown in Fig. 4-4a, the concentrations of the coated 1
st
 Ab were investigated in 
the range of 2 - 60 μg/mL while the h-IgA concentration was fixed at the 100 ng/mL. As 
shown in the figure, the fluorescence intensity of the signal increased dramatically up to a 
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concentration of coated 1
st
 Ab of 10 μg/mL. We chose 10 μg/mL of the 1st Ab for the 
designed microassay. Fig. 4-4b shows the influence of incubation time in the microwell 
immunoassay. The optimal incubation time was determined to be 10 min. As a result, the 
incubation time was greatly decreased from hours to minutes compared with that for the 
96-well plate shown in Table 4-1. The reason for this can be attributed to the shorter 
diffusion distance of the microchannel inside the MCP.
 
To investigate the speed of the 
enzyme catalytic reaction and determine the optimal detection time, plots of the enzyme 
reaction kinetics of the substrate solution were recorded as shown in Fig. 4-4c. The 
fluorescence signal increased rapidly up to a time of 200s after the substrate introduction. 
Thus, the measurements were performed at 220s in the following experiments. 
Additionally, the effect of the 2
nd
 Ab was also investigated, in an attempt to further 
enhance the efficiency of enzymatic reaction and to decrease the background. As shown in 
Fig. 4-4d, 0.5, 2.5 and 5 μg/mL of the 2nd Ab solutions were investigated, respectively. 
The data showed that a lower concentration of 2
nd
 Ab resulted in a lower signal intensity 
and a poor correlation. To the contrary, the higher concentration of the 2
nd
 Ab generated a 
higher background signal and relative standard deviation (RSD). Therefore, 2.5 μg/mL of 
2
nd
 Ab was selected as the optimal concentration considering the background and RSD.   
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Fig. 4-4. Investigation of optimum conditions for ELISA on a microwell array on MCP. 
(a) Effect of the concentration of coating Ab on ELISA. H-IgA: 0.2 ng/well, incubation 
time: 30 min under 97% RH, 37 ºC; (b) Influence of incubation time on ELISA 
performance. Coating Ab: 10 μg/mL, h-IgA: 0.2 ng/well; (c) Kinetic curves of the 
Amplex® Red substrate reaction with the H2O2 catalyzed by 2
nd
 Ab. Coating Ab: 10 
μg/mL, h-IgA: 0.02 ng/well, 0.2 ng/well; (d) Effect of the concentration of 2nd Ab on the 
measurement of h-IgA in microwell array on MCP. 
4.3.5. Investigation the effects of blocking 
The specificity and sensitivity of the assay can be influenced by the non-specific 
adsorption (NSA) of other proteins or biomolecules by occupying the active sites of the 
valid surface. Actually, various strategies have been employed to reduce NSA, in attempts 
to decrease the background signal, and enhance the sensitivity of an immunoassay. A 
simple strategy, involving surface blocking, is usually adopted to reduce the NSA. 
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Therefore, we investigated the blocking conditions. Experimentally, bovine serum 
albumin (BSA), casein, and SuperBlock buffer were used to search for the best blocking 
option. Fig. 4-5 illustrates the blocking efficiencies of the above blocking solutions. The 
BSA solution obviously showed best blocking efficiency. Thus, a 1% BSA solution was 
the most efficient, and was adopted in the following experiments.  
 
Fig.4-5. Effect of blocking solutions on the ELISA performed in a microwell array on 
MCP. The signal to noise ratio (S/N) was calculated from the fluorescence intensity of 100 
ng/mL h-IgA solution (S) divided by the blank signal (N).  
4.3.6. Investigation the influence of substrate concentration and the 
calibration of h-IgA  
In order to obtain the optimum sensitivity in an immunoassay, the reaction between 
Amplex
®
 Red and H2O2 catalyzed by the HRP-conjugated antibody (i.e. 2
nd
 Ab) was 
investigated. As shown in Fig. 4-6a, the signal intensity was increased with increasing 
concentration of substrate in the enzyme reaction. While for the present method, the 
optimum concentration of the substrate was selected as 6.9 mmol/L,
 
since the curve 
reached a plateau at that concentration. This ensured that the quantitative measurement of 
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ELISA in the microwell array was possible in the present immune approach. Therefore, 
h-IgA was measured by the present microwell immunoassay under optimal conditions. 
From the results shown in Fig. 4-6b, the assay was a success and showed a high sensitivity. 
Because of the microsize of the well, sample consumption was cut to 2 μL/well, thus the 
absolute amount of target could be dramatically decreased. Meanwhile, the LOD was 
calculated to be 0.05 ng/mL by the average signal of the blank (Sblank) plus three times 
the standard deviation of the blank (3SD) [6,25]. The contradistinctive data for h-IgA 
measurements by the microwell array and the 96-well plate method are listed in Table 4-2. 
The method showed a better LOD than the traditional 96-well plate method. Regarding 
reagent consumption, the immunoassay time and the size of the device, the proposed 
MCP-based microwell was superior to those for the traditional 96-well plate. 
 
Fig.4-6. Effects of the substrate concentrations on the enzyme catalytic reaction 
performed in the present method, the other conditions were used with the optimal 
ones as the former works investigated (a). Plot for h-IgA detected by the present 
method under the optimized conditions (b).  
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Table 4-2. Comparison of the ELISA performance in present microwell array and 96-well 
plate.  
  Microwell 96-well plate 
Reagents consumption / (μL) Goat anti-h IgA solution 2 100 
Blocking buffer 2.5 200 
Antigen/sediment solution 2 100 
HRP-conjugated goat anti-h 
IgA solution 
2 100 
Substrate solution 2.5 100 
Washing buffer 42 2400 
Total reagents consumption / (mL)  0.053 3 
Assay time / (min)  25 135 
LOD / (ng/mL)  0.05 5.19 
4.3.7. Comparing with 96-well plate in the measurement of saliva  
    Saliva is an important bodily fluid, and samples can be obtained easily and 
noninvasively. Moreover, it contains various substances and biomarkers that can be used 
as indicators of health and disease status [26,27].
 
To evaluate the applicability of the 
present method in a practical ELISA, h-IgA in saliva samples were measured, and it was 
also measured by the 96-well plate method as a reference. Saliva samples were collected 
from 6 healthy adults. The resulting samples were diluted with PBS buffer, and assayed.  
   Since problems associated with matrix effects and working range are frequently 
encountered in measurements of biological samples. We investigated the dilution factors 
in the measurements of h-IgA by the proposed microwell approach and the 96-well plate 
method. Based on different sample dilutions, the findings show that the microwell method 
showed a good relative analytical sensitivity and a good dilution tolerance in h-IgA 
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measurements. As can be seen in Fig.4-6, h-IgA in 6 saliva samples at a 500-fold dilution 
were tested by the two methods and the results were highly correlated (r
2
=0.91).   
 
Fig.4-6. Measurements of saliva sediments by the present microwell and 96-well 
plate method: Investigations of the dilution factor on the measurement of h-IgA (a); 
Detection concentrations of h-IgA in saliva samples with 500-fold dilutions (b). 
In addition, when recovery trials by adding standard h-IgA were carried out by the 
proposed method, the obtained recovery ratio was in the scope of 93.7-112.2%(Table 4-3). 
Table 4-3. Investigation of recoveries for h-IgA in saliva samples by the proposed 
microwell array. 
Sample h-IgA addition   Detection   Recovery 
ng/mL   ng/mL   
1 0 190.83 --- 
25 214.25 93.7% 
50 242.25 102.8% 
2 0 218.83 --- 
25 242.65 95.28% 
50 274.93 112.2% 
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4.4. Conclusions 
The design of a novel compact immunoassay using a MCP constructed microwell 
array is described. The enlarged surface area and decreased microsize of the condensed 
micro channels in the MCP resulted in a rapid and efficient Ab-Ag recognition. 
Additionally, by taking advantage of the large surface area-to-volume ratio and a 
microwell array, the performance of the immunoassay was fast, involved minimal sample 
consumption as well as high-density measurements. This permits a high-throughput 
detection to be performed on a 20-mm square MCP with a high degree of sensitivity, a 
short assay time and simple construction. The developed immunoassay method was 
successfully used in the measurement of h-IgA and the results were in agreement with 
results obtained using the traditional 96-well plate method. The use of the method for 
analyzing saliva samples suggests that the method has the potential for use in on-site 
diagnostics. For the further enhancement in detection sensitivity, the large amount of 
sample could be accepted because of the high surface area of this method. Thus the 
proposed method could be greatly improved by using an on-line concentration method, 
which is now being pursued in our laboratory.  
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Chapter 5. A simple and open microarray integrated with PDMS 
microwells for Rift Valley fever virus nucleoprotein measurement 
Abstract  
A simple and open PDMS microarray was constructed for immunoassay. The device 
consisted two pieces of PDMS layer, the upper layer with hole-array to confine the open 
well array and the bottom layer with microwells integrated to enhance surface area. 
Primarily, h-IgA was taken as a model to investigate the system in terms of incubation 
time and working efficiency. The results showed an enhanced detection performed on the 
microwell integrated microarray compared to a flat well microarray. Additionally, a 
further enhancement was obtained as the microarray functionalized with 
3-aminopropyl-triethoxy-silane (APTES), which demonstrated the electrostatic adsorption 
with higher immobilization efficiency compared to the simple physisorption. Finally, the 
microwells integrated microarray with APTES modification was successfully used to Rift 
Valley fever virus (RVFV) recombination nucleoprotein (rNP) measurement. These 
results pointed that the PDMS microarray with simple and open wells could be used for 
rapid and quantitative immunoassay besides the benefits of low-cost, easy-fabrication and 
less-apparatus requirement. The microarray integrated point-of-care system could be a 
great potential for on-field and on-time applications in biological and medical assay. 
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5.1. Introduction  
Current requirements of potable and disposable diagnostic devices for biological and 
biomedical research are greatly increased [1-4]. The area of micro total analysis systems 
(μTAS) provides numerous benefits due to the downscaling process. One of the significant 
examples is the point-of-care (POC) microsystems [5-8]. Immunoassay, based on highly 
specific antibody-antigen interactions for biochemistry analyses, has been widely 
exploited in combination with microfluidic techniques. Such systems have clearly 
demonstrated numerous advantages including miniaturization, fast reaction kinetics, low 
sample/reagent consumption, portable utilization, and so on [9-11].  
One of the significant advantages offered by the microfluidic devices is the reduction 
of analysis time from hours to minutes, owing to the high surface-to-volume ratio and 
short molecular diffusion distance [12]. Among various microfluidic systems, poly 
(dimethylsiloxane) (PDMS)-based microfluidic devices are most popular due to its 
low-cost, easy fabrication, nontoxicity, convenient handling [13-14]. PDMS is an elastic 
polymer and has been employed extensively for surface adsorption and biomedical 
applications [11, 15]. A vast number of microfluidic integrated immunoassays have been 
developed to miniaturize the system and to improve analytical efficiency. Meanwhile, it 
can readily realize high throughput and multiple measurements with low consumption and 
fast assay [16-17].  
However, there are still some challenges on PDMS-based system due to the 
hydrophobic of PDMS. In view of this, many efforts have been taken to investigate the 
surface modification of PDMS to increase the efficiency of antibody immobilization [18]. 
Among them, silanization with (3-Aminopropyl)triethoxysilane (APTES) is one of the 
most popular approaches for activation of the surface [13, 19], which can change the 
PDMS surface less hydrophobic and supply a positively charged surface. APTES modified 
surface with amino end can be used to immobilize antibodies onto the surface either 
through covalent binding or physical adsorption including electrostatic adsorption. 
Moreover, a reported work demonstrated that the surface protein binding capacity on 
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APTES functionalized surfaces obtained through physical adsorption was superior to that 
obtained through covalent binding by employing glutaraldehyde as bifunctional ligand for 
protein coupling [20]. 
The growing requirements for high-throughput, multiple, automatic and ultrasensitive 
assay have promoted the development of multi-integration in the microfluidic system. 
Particularly, the interaction of the immunoassay system on a microfabricated arrays is a 
very promising approach [21-22]. Generally, microfluidic immunoassays are performed in 
a closed flow channel in which sample/reagent solutions are introduced sequentially into 
the microchannel by using different strategies, such as syringe pumps [23], centrifugal 
microfluidics [24], capillary based pressure [25-26]. In spite of various advantages, the 
requirements of many extra power or apparatus make it difficult to use in terms of cheap, 
portable and simple. Compared with the flow system in closed channels, an open 
microarray system will be appealing with benefits of simple to use, high-throughput and 
multiple assays, as well as portable and disposable. In addition, the open microarray 
device can be well integrated with inkjet injection and electro-controlling movement of 
x-y-z stage to realize automatic performance in immunoassay.  
Here, a simple and open microarray was fabricated by assembling two PDMS layers. 
The device was designed with microwell integrated arrays to increase surface area and the 
surface-to-volume ratio, which is aimed to improve the efficiency of immunoassay. 
Primarily, the system was evaluated by h-IgA tests. From the results, it can be performed 
easily with fast and enhanced immunoassay. Additionally, the microdevice modified with 
APTES was also successfully used for the measurement of antigen (RVFV-rNP) to Rift 
Valley fever virus (RVFV), which can infect disease in animals and humans. The 
emergence of RVF and effects of damage have raised international concern since the virus 
can be widely spread by mosquito vectors [27-28]. Diagnosis of Rift Valley Fever (RVF) 
can be performed by virus isolation, nucleic acid techniques, and viral antigen or antibody. 
In view of safety, high efficiency and equipment requiring, immunoassay is a popular 
method and has been widely used in RVFV diagnostics [29-31]. Although development of 
these immunoassays addressed an increased international demand for standardized and 
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validated tools, there is still a great requirement of new diagnostic platforms which could 
be easily used with portability and disposability under field settings. Thus, microfluidic 
immunoassay with open microarrays supplies various advantages, such as simple 
fabrication, low cost, less apparatus requirement and easy to use. The microdevice holds 
significant promise for immune clinical, biomark screening/monitoring, and also POC use 
for field detection. 
5.2. Experimental  
 5.2.1. Materials and apparatus 
A PDMS kit (Silpot 184) was obtained from Dow Corning Toray (Tokyo, Japan). 
SU-8 3050 negative photoresist and SU-8 developer were obtained from Nippon Kayaku 
Co. Ltd. (Tokyo, Japan). Silicon wafer was got from Xilika Co. (Tianjin, China). 
Trichloro-(1H, 1H, 2H, 2H-perfluorooctyl) silicone was bought from Sigma-Aldrich. 
APTES and super dehydrated ethanol was obtained from Wako Pure Chemical Industries 
Ltd. (Osaka, Japan). A human IgA kit, including affinity purified goat anti-human IgA 
(cAb), a human reference serum solution and goat anti-human IgA HRP conjugated (dAb), 
was obtained from Bethyl Laboratories (Montgomery, USA). Bovine serum albumin 
(BSA) was obtained from Merck (Calbiochem, German). Amplex
®
 Red reagent was 
purchased from Life technology of Invitrogen (Eugene, USA). Na2HPO4, NaH2PO4, H2O2 
and H2SO4 (98%) were purchased from Wako Pure Chemical Industries Ltd. (Osaka, 
Japan). Washing buffer (PBST) was prepared with 0.5% (w/v) BSA/0.1% (v/v) Tween-20 
(Kanto Chemical Co., Inc., Tokyo, Japan) in 50 mmol/L PBS (pH=7.4). All solutions and 
buffers were prepared with deionized water purified by Milli-Q system from Nihon 
Millipore (Tokyo, Japan). Reagents for RVFV-rNP detection, including monoclonal 
antibody (MAb), RVFV-rNP antigens and negative control recombinant antigens, rabbit 
anti-serum raised His-RVFV rNP (1
st 
antibody) were kindly obtained from National 
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Institute of Infectious Disease (Tokyo, Japan). Horseradish peroxidase-conjugated goat 
anti-rabbit IgG (2
nd
 antibody) was bought from Invitrogen Co., (Camarillo, USA). 
A photoresist spinner (K-359-S-1) was obtained from Kyowariken Co. LTD. (Tokyo, 
Japan). An exposure machine (Box-w98) was obtained from Sanhayato Co. LTD. (Tokyo, 
Japan). An air pump (LMP100) was obtained from Asone Co. LTD. (Tokyo, Japan). A 
high frequency generator used for plasma treating was obtained from Electro-technic 
products, Inc. (Chicago, USA). An Espec ST-110 high temperature oven (Osaka, Japan) 
was used for the PDMS thermo-curing. An incident light fluorescence microscope (BX-51, 
Olympus, Tokyo, Japan) system equipped with filter set XF-102 (for Resorufin, Opto 
Science, Inc.) integrated with a 543.5 nm laser (3478EC, Melles Griot, Carlsbad, 
California, USA). The fluorescence signal was detected by a photomultiplier (PMT) 
(H7422-40, Hamamatsu Photonics, Japan), and the signal was amplified by means of a 
laboratory-made current amplifier, the magnified analog signal was then converted to 
digital data by a 12-bit A/D converter (PicoScope 4224, Pico Technology, Cambridge 
shire, UK) and recorded with a PC (Dell Inc., DCNE, China). 
 5.2.2. Fabrication of the microarray and surface modification with 
APTES  
General approach for microarray fabrication with polydimethylsiloxane (PDMS) is 
fabricated by standard soft photolithography using SU-8 photoresist [32]. Mask patterns 
for microstructures were primarily designed with Illustrator CS4 (Adobe) and printed onto 
a transparent film (Fig.5-1A). The procedure for PDMS layer fabrication has been 
reported previously [33]. Briefly, as schematically outlined in Fig.5-1B, a silicon wafer 
was firstly cleaned by a piranha solution of 30% hydrogen peroxide (H2O2) and 
concentrated sulfuric acid (H2SO4) (1:3 v/v) with weakly boiling for 1h. After thoroughly 
rinsing with water, the wafer was drying by the stream of N2 and heated on a hot plate at 
110 °C for 30 min to remove the residual water. Next, a layer of SU-8 photoresist was 
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spun onto the silicon wafer (800 rpm for 1.5 min) and pre-baked to drive-off the solvent at 
60℃ for 10 min and 90℃ 20 min, respectively. 
   
Fig.5-1. Drawing of the photomask with microwell arrays (A). Schematic presentation of 
the procedure for microarray fabrication and surface modification with APTES (B). 
In the experiment, 3 times repeat coating and drying were performed to make a thick 
layer of photoresist. Then the pattern-printed photomask was aligned onto the 
photoresist-coated wafer and exposed for 7min and 5min, sequentially. After post-baking 
at 60 ℃ for 10 min, the photoresist was developed in SU-8 developer with shaking for 20 
min, and cleaned by 2-proponal. To make a patterned PDMS slide, a curing agent and 
PDMS pre-polymer were thoroughly mixed with 1:10 weight ratio and degassed in a 
desiccator with vacuum pump. Then the mixture was poured onto the wafer mold and 
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thermally cured at 60℃ for 2h in an oven. After curing, the PDMS replica was peeled off 
and trimmed to an appropriate shape. At the same time, a flat PDMS slide was also made 
by pouring PDMS mixture onto a flat glass plate surface and cured, followed by peeling, 
trimming and punching hole-array.  
To modify PDMS surface, the cleaned PDMS surface with microwell structure was 
firstly pretreated by air–plasma for 2 min, then immersed into a freshly prepared APTES 
solution (5% in super dehydrated ethanol) for 2h at room temperature (RT). After the 
silane coupling reaction, the slide was rinsed with pure ethanol two times and thoroughly 
cleaned by deionized water, then dried under a stream of nitrogen followed by heating at 
100 ℃ for 5 min in an oven. 
The microarray was constructed by two layers of PDMS, which were perpendicularly 
sealed by irreversible bonding after an air-plasma treating for 1 min. while, APTES 
modified PDMS surface was bonded to the hole-punched flat layer by adhesive approach, 
in which the surface of the up flat layer was dipped a thin layer of pre-polymer mixture of 
PDMS, and vertically attached to the microwell integrated PDMS surface, then put into an 
oven for thermally bonding at 100 ℃ for 30 min. 
 5.2.3. Performance of h-IgA measurement 
The measurement of h-IgA was performed by a traditional sandwich immunoassay, 
an enzyme-linked immunoassay (ELISA). cAb solution at the concentration of 10 μg/mL 
was pipetted into each well of the microarray device at an amount of 3.0 μL/well. A 
plastic film was overed onto the well array for incubation with 30 min at RT. After 
incubation, wastes were emptied by vacuo and washing was performed by PBST with 6.0 
μL/well for three times. A BSA (1%, w/v) solution was next introduced into each 
microwell with 5.0 μL/well for blocking. After 30 min incubation, 3 washings with PBST 
buffer (6.0 μL/well) were done. Then, different concentrations of h-IgA solution were 
introduced into each microwell (3.0 μL/well). After incubation, the microwell array was 
washed 3 times with PBST buffer. Then, dAb solution (2.5μL at 10 μg/mL) was pipetted 
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into wells of microarray at a volume of 3 μl/well. After 30 min incubation, the 
unabsorbed antibodies were removed by washing 5 times with PBST buffer. Finally, 5.0 
μL/well of an Amplex® Red substrate solution was pipetted into each well to generate 
Resorufin for fluorescence detection.   
 5.2.4. Protocol of antigen capture immunoassay for RVFV-rNP 
An antigen capture immunoassay was carried out for RVFV-rNP detection, the 
protocol was schematically illustrated in Fig.5-2.Briefly, puriﬁed MAb, raised against the 
recombinant antigen of RVFV (RVFV-rNP) (D5-59) was coated onto the inner surface of 
APTES modified microarray at a 10 μg/mL with the introduction of 3μL/well, and 
incubated for 30 min at RT with a plastic film covered. After incubation, the wastes were 
vacated and the wells were washed by PBST (6 μL/well) for 3 times. Followed by 
blocking with BSA (1%) solution for 30 min at RT, the wasts were discarded and the 
wells were washed three times by PBST with 6 μL/well. Next, recombinant test antigen of 
RVFV (RVFV-rNP) and negative control recombinant antigens (EBO-rNP) with different 
dilutions from 200 ng/mL to 0.2 ng/mL were then serially pipetted into wells. Followed by 
30 min incubation at RT, the wastes were discarded and the wells were washed three times 
by PBST with 6 μL/well. 1st antibody (Polyclonal antibody raised in rabbits by 
immunization with the puriﬁed His-RVFV rNP) diluted to 1:1000 was added to each well. 
This was followed by incubation for 30 min at RT. Then, the wastes were discarded and 
the wells were washed 3 times by PBST with 6 μL/well. Next, 2nd antibody of 
horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG with 1:1000 dilution were 
pipetted into each well. After 30 min incubation at RT, the contents were discarded and 
the wells were washed 5 times by PBST with 6 μL/well. Finally, 5 μL/well of Amplex® 
Red substrate solution was added and the fluorescence signal was measured by 
laser-induced fluorescence method. Means and standard deviations were calculated from 
the intensity values with 3 replicas, and the cutoff value for the assay was deﬁned as the 
mean plus three times of standard deviations. 
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Fig.5-2. Illustration of antigen capture immunoassay for RVFV-rNP detection. 
5.3. Results and discussion 
5.3.1. Performance of immunoassay in microwell integrated device  
As shown in Fig. 5-3, it schematically illustrated the construction of the microarray 
system with two PDMS layers (Fig.5-3A) and the size of each well (Fig.5-3B), as well as 
the performance of a sandwich immunoassay by using the device (Fig.5-3D). In this work, 
the microwell integrated PDMS surface (Fig.5-3B) was used to increase the surface area 
and the ratio of surface-to-volume, since the immobilization and reaction kinetics are 
effected greatly by the two aspects [11, 34]. Actually, various strategies have been 
exploited to enhance the immunoassay with quick and sensitive analysis via the 
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enhancement of these two points [35-37]. Thus, the aims of this work were to setup a 
simple and easy-to-use microdevice based on PDMS microfluidic technique, which was 
used for fast and quantitative detection of infectious disease.  
 As is known to us, PDMS surface is hydrophobic and easily adsorb proteins 
including the high non-specific adsorption. What’s more, the hydrophobic property makes 
it difficult wet by aqueous solution. However, the PDMS surface can be changed to less 
hydrophobic or hydrophilic by surface modification or oxygen plasma treatment. The 
latter method is easy, but the hydrophobicity can be recovered after a short time. On the 
contrary, the surface modification can permanently and flexibly change its surface. 
Among them, APTES treatment is one of the most popular methods to graft its propyl 
amine group onto the PDMS surface. The method not only rendered the surfaces 
hydrophilic but also supplied a positively charged surface in a buffer solution at pH 7.4 
[38]. As a result, protein immobilization was enhanced with high efficiency. Because 
surface forces governing protein adsorption include steric forces, electro-static forces, 
hydrophobic interactions and van der Waals (vdW) forces. Among them, a main effect 
comes from the surface properties, such as morphology, wetting and surface charge. 
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Fig.5-3. Schematics of microwell-fabricated microarray by two PDMS layers (A). 
Partial view of the bottom layer with microwells integrated (B). Diagram of the 
microarray device with dimensions for each well (C) and draft with theoretical 
performance of sandwich immunoassay in a well (D). 
As APTES modified onto PDMS surface, the primary treatment of PDMS surface is 
necessary due to its lack of active sites. While, air plasma is an easy and fast method to 
change the PDMS surface to be hydrophilic and form an active layer with silica and 
silanol (Si–OH) groups which can be used to silanize with APTES. Since the plasma 
treatments preferentially remove hydrocarbon fragments from the PDMS surface, the 
amine-modified PDMS surface cannot be pretreated by air–plasma when it irreversibly 
bound to the other materials, as shown in Fig.5-1B. 
5.3.2. Efficiency of immunoassay by the microarray devices 
The aim of the work is to design a microarray device for quick, sensitive and 
quantitative diagnostic, besides portable and disposable POC applications. Thus, 
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validation of the efficiency of immunoassay by the device is essential. In this work, three 
types of microdevices, including 1) a flat bottom layer constructed microarray, 2) a 
microwell-integrated bottom layer constructed microarray and 3) an APTES treated 
microwell-integrated bottom layer constructed microarray, with different surface geometry 
and chemicals, are investigated. And the performances of the three devices were compared. 
Here, h-IgA was taken as a model sample, and three types of microdevices were 
investigated through the relationship between incubation time and signal intensity, 
considering the assay speed and sensitivity. Amounts of immobilized antibodies dominate 
the reaction efficiency of antibody/antigen and analytical sensitivity. Thus, there are 
various immobilization approaches employed for proteins binding to a surface. The 
simplest one is physisorption, which requires no toxic reagents and no sophisticated 
chemical protocols. PDMS is hydrophobic in native form, so proteins are readily adsorbed 
onto its bare surface via intermolecular forces such as electrostatic, hydrophobic, van der 
Waals or combination of those. As can be seen in Fig.5-4, the reactions reached to a 
plateau at different time and the corresponding signal intensities were different. The 
APTES treated microdevice showed best signal response and a quick reach to the plateau. 
The reason maybe that APTES modified PDMS surfaces offered a positively charged 
surface and allowed to bind to the anionic carboxylate groups of Abs via electrostatic 
interactions [38]. From the results, the flat PDMS microdevice gave inferior measurement, 
though the incubation time was comparative with the microwell-integrated microdevice. 
Totally, the PDMS fabricated microdevice demonstrated preponderance in short 
incubation time requirement in comparison with the traditional 96-well microtiter plate 
method. 
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Fig.5-4. Investigation of relationship between incubation time and signal intensity by 
h-IgA measurement. The immunoassay was performed by three types of microdevices, 
including a flat bottom layer constructed microarray (black square), a 
microwell-integrated bottom layer constructed microarray (red dot) and an APTEM 
treated microwell-integrated bottom layer constructed microarray (blue triangle).  
5.3.3. Investigation of calibration by the microdevice 
Calibration of h-IgA was also investigated by the three types of microdevices. 
From the graph in Fig.5-5, the APTES modified microarray showed superior working 
efficiency with highest sensitivity, and the flat PDMS constructed microarray gave the 
results as expected with low sensitivity. These were coincident with the former results 
that the working efficiency of the microdevices enhanced from flat surface to APTES 
treated surface due to the increase of binding force between protein and surface.     
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Fig.5-5. Investigation of calibration for h-IgA measurement by the three 
microdevices. 
Table 5-1. Comparison of the quantitative detection by the microdevices 
 Plot equation  
R
2
 
LOD 
(ng/mL) 
Flat well Y=0.7243+1.3275 x lgX 0.9462 3.989 
No-treated microwell Y=0.0453+2.2515 x lgX 0.9246 3.739 
APTES-treated microwell Y=0.1021+2.8409 x lgX 0.9971 2.406 
5.3.4. Measurement of RVFV-rNP antigen 
Based on the evaluation and validation the microarray device, RVFV-rNP antigen 
was also detected by the APTES modified device, the results can be seen in Fig.5-6. In 
the experiment, the monoclonal IgG antibody of RVFV-rNP was primarily 
immobilized onto the APTES-treated innersurface of microwells. The antigen capture 
immunoassay for RVFV-rNP was performed following the protocol as listed in 
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experimental part. The investigation of quantitative detection was carried out with the 
antigen concentration in the scope of 200 ng/mL to 0.2 ng/mL. As shown in the graph, 
the cut-cross with quite low signals demonstrated a high specific and sensitive 
measurement for RVFV-rNP antigen by the present microarray device.  
 
 
Fig.5-6. Working plot for RVFV-rNP measurement by the APTES modified 
microdevice. 
5.4. Characteristics of the 3D microarray and the comparisons  
In this thesis, a new platform based on 3D microarray has been developed for 
immunoassay. The characteristics lead to a great improvement for immunoassay 
compared to the traditional 96-well microtiter plate method. The main points are coming 
from the microsize effect, large surface-to-volume ratio, short diffusion distance, high 
density and high throughput detection. Especially, the MCP-based microarray affords 
better performance in view of flow-controlling system, either by an extra pump or by 
capillary action. Meanwhile, a MCP-absent system fabricated by PDMS microwell was 
also shown potential in 3D microarray for immunoassay, due to the merits and popular 
application of PDMS itself in terms of low cost, easy fabrication, high integration, and so 
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on. Because of the similar merits coming from PDMS-microwell based 3D system, 
including microarray assay, microwell-integration, high surface-to-volume ratio, short 
diffusion distance, microsize, low consumption, etc. the results validated its feasibility 
and advantages in immunoassay. Comparisons for MCP-based system with 96-well plate 
has been illustrated in chapter 3, while here is a further comparison between the 
MCP-based microarray and PDMS microwell integrated microarray. As shown in Table 
5-2, some physical parameters and detection results have been compared. The 3-D 
system provides various merits for micro-immunoassay with fast assay and sensitivity 
detection. What's more, MCP-based microarray overwhelmed PDMS system in reaction 
efficiency and performance. While in terms of cost, integration and fabrication, PDMS 
system is popular. 
Anyway, the present 3-D system with open microarray is combined with microfluidic 
technique and high density parallel detection, which supplied numerous advantages for 
immunoassay compared to the traditional method, or the microparticle-based system, even 
to the channel fabricated chip techniques. It demonstrates a great potential utilization in 
immunoassay for field or POC detection.  
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Table 5-2. Comparison between PDMS microwell integrated system and MCP-based  
microarray for immunoassay, including physical parameters and detection efficiency. 
3D microarray 
 
Factors 
 
 
Open ratio 36.96% 50.24% 
Surface area  
(mm
2
) 
26.67 492.98 
Surface-to-volume 
ratio 
3373.3 200 
Diffusion distance 50 μm 10 μm 
Well size Φ = 2.5 mm Φ = 2.5 mm 
Reagent 
consumption/well 
3 μL 2.5 μL 
Incubation time for 
h-IgA 
15 min 10 min 
Detection limit 2.4 ng/mL 0.05 ng/mL 
5.5. Conclusions  
 In summary, we have developed a simple and open PDMS microarray for 
immunoassay. The microwell-integrated PDMS surface can be easily modified with 
APTES, which can change the native hydrophobic PDMS surface to less hydrophobic and 
positively charging. Proteins immobilized onto the surface by the simple physisorption 
together with the enhanced electrostatic force, which enabled a fast and sensitive 
quantification for h-IgA. Meanwhile, RVFV-rNP antigen was also successfully detected 
by the microdevice with high specific and sensitivity. The present system was 
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operationally simple and offered a route to reduce cost and increase efficiency to common 
laboratories approach. In addition, PDMS-based microassays make the POC for medical 
and clinical diagnosis easier and manifest great potentials in wide applications. The 
microarray system also can be easily expanded in the future to test additional samples and 
more analytes in parallel. 
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Chapter 6. Summary and the prospect 
6.1. Summary 
Miniaturized diagnostic devices and enhanced efficient recognition hold great 
promise in specific and sensitive detection of various biomarkers to early diagnosis and 
treatment of diseases. Especially, the development of immunoassay technology is 
increasingly demanded in diagnostics of disease, like infectious disease. The 
immunoassay systems integrated microfluidic techniques with open microarrays in our 
work show potentials for application in field of diagnostics. In addition, it is easily 
facilitated to the POC system employed in the clinical laboratory or on-field testing.  
In this thesis work, we developed a compact immunoassay system, which combines 
the multicapillary glass plate (MCP) system and microfluidic techniques. Micro-channels 
in the MCP are used for reaction place for immunoassays, here ELISA is the main form to 
be used. On one hand, the capacity of cAb immobilized onto the inner surface of the 
channel is greatly enhanced due to the compact micro-channels, compared to a single 
ordinary capillary or microfluidic channel. On the other hand, the largely decreased size of 
the micro-channel affords a short diffusion distance, which enable fast diffusion and quick 
assay. At the same time, PDMS as a popular material for chip fabrication can be made 
with hole-array and attached to the surface of MCP to form the microarray device, which 
is small size, renewed and portable. Furthermore, the micro-device fabricated by MCP and 
PDMS slides is transparent which can be easily observed on a microscope system and 
detected by optical method. Thus, a compact immunoassay based on the MCP constructed 
microarray device incorporating pump-driving and capillary force-driving flow has been 
developed for immunoassays.  
To speak of electro-controlling x-y stage and inkjet injection system, the former part 
can easily manipulate the movement of detection point in microarray device to realize 
large-scale measurements; while the later mentioned inkjet injection, a 4-channel injection 
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chip with serial reagent loading and pico/nano liter level of injection, is well compatible to 
the open well-array for solutions introduction. Alternatively, an open PDMS chamber 
array with microwell-fabricated in the bottom combined with the inkjet injection has great 
promising applications to immunoassays. The high surface area of microwells results in a 
high possibility for Abs immobilization and provides an increasing detection limit. This 
method is expected to have excellent compatibility with general diagnostics, as well as 
high potential to be a POC testing system in the future. 
In summary, a micro-immunoassay platform based on a MCP and a PDMS 
microarray has been developed. Due to the advantages of small size and micro array, the 
device can be used to perform immunoassay tests with rapid and high throughput 
detection. Additionally, the developed microsystem has potential in POC applications and 
on-site diagnostics. In view of this, ELISA, one of the most widely used approaches in 
clinical diagnostics and biomark detections, was performed with h-IgA measurements. 
Traditionally, the technology is carried out in a 96-well microtiter plate and involves a 
series of tedious processes, including sample introduction, serial incubation and washing. 
Moreover, substantial amounts of samples and reagents are consumed and the method is 
time-consuming, and sometimes is hampered by low sensitivities. In order to overcome 
these challenges, micro-structure based system was exploited for immunoassay in the 
work. The micro dimension system has numerous size affection attributes, such as a 
higher surface-to-volume ratio, shorter diffusion distance and a lower consumption of 
reagents. It affords greater benefits for this micro-immunoassays system.  
At first, a novel and accelerated ELISA based on MCP-assembled microfluidic 
chambers with flow-injection was developed for immunoassay. MCP, containing 
uniformly arrayed microchannels, was used as the solid phase substrate for coating 
antibodies. The device was developed by the juxtaposition of the MCP with two pieces of 
well-fabricated PDMS slides with punched holes that are used for the introduction and 
exit of samples and reagents. The biological reaction takes place on the inner surface of 
the micro-channels to mimic the principle of a microanalysis when using normal 
amounts of sample. In addition, the effective surface area for protein immobilization is 
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increased considerably, compared to a planar substrate or a single glass capillary. The 
flow injection method was carried out by introducing solutions into the reaction chamber 
with a pump, and the amount of protein coated on the inner surface of the micro-channels 
increased. The microfluidic device was used to detect human immunoglobulin-A (h-IgA) 
in a reference of human serum, where the antigenic conditions for the sandwich 
immunoassay were optimized. The analysis time was shortened to less than 1.0 hour.  
Next, a highly sensitive and rapid immunoassay using a batch method was realized 
in multi-channels of a micro-well array consisting of a MCP and a PDMS slide. The 
method decreased the total time of the immunoassay by 1/5, and reduced reagent 
consumption to 1/56 of a fraction compared to the standard method. In addition, the LOD 
for the detection of h-IgA was 0.05 ng/mL. The method was then tested using actual 
saliva samples obtained from healthy volunteers. The results were in good agreement 
with data obtained using the standard 96-well plate method. Thus, this method has 
tremendous potential for use in automated and on-site immunoassays. And it is expected 
to speed up disease diagnosis, and to act as a rapid clinical and public health tool in the 
future. 
Additionally, the PDMS polymer itself has been vastly popular for antibody 
immobilization in immunoassays. As such, a simple, low-cost and open PDMS 
microarray was explored for its potential application in immunoassays. The development 
and construction of a simple and open PDMS microarray for use in a 
micro-immunoassay is discussed. The device consists of two PDMS slides. The upper 
layer with a hole-array was used to confine the open well array and the bottom layer with 
microwells was utilized to enhance the surface area. The optimization involved the use of 
h-IgA to decipher the optimized incubation time and working efficiency of the system. 
The results showed a greater enhancement for the immunoassay performed on the 
microwell integrated microarray compared to a flat well microarray. Additionally, a 
further enhancement was obtained by functionalizing the microarray with APTES due to 
the enhanced electrostatic adsorption. The microwells integrated microarray modified 
with APTES could also be successfully used in the performance of antigen capture 
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ELISA. The detection of the Rift Valley fever virus (RVFV) was carried out by the 
detection of its recombinant nucleoprotein (rNP). These results indicate that the PDMS 
microarray can be used for a quantitative immunoassay and is a simple, rapid and 
sensitive assay. Other advantages include low-cost, ease of fabrication and minimal 
apparatus. The microwell-integrated PDMS surface can be modified with APTES, which 
can render the native hydrophobic PDMS surface less hydrophobic, thus permitting a 
positive charge. This work represents the initial efforts towards developing a microarray 
immunoassay, which has the potential of achieving high throughput and sensitive 
analysis.  
In conclusion, micro-immunoassays have been developed by the use of a MCP and 
PDMS microarray. The MCP-based micro device was demonstrated to have numerous 
advantages for use in an immunoassay. The use of compact microchannels for 
antibody/antigen immobilization and immunogenicity detection is nonetheless a practical 
and cost-efficient way to increase the sensitivity and enhance the efficiency of such a 
system. Meanwhile, the PDMS-based micro device rendered the immunoassay simple 
and cost-efficient for use. The system can be modified to permit complete multiple 
measurements to be made with numerous advantages as detailed above, which allows the 
potential of POC system for use in the diagnosis of diseases.  
6.2. The prospects 
A fast and sensitive immunoassay is extremely important to determine its successful 
employment as a diagnostic tool. There are still challenging in the POC testing which is 
greatly demanded for routine using in hospital or at home. More efforts also need to be 
conducted on these systems to realize clinical samples testing. In this thesis work, a 
MCP-based microdevice, is shown to have numerous advantages for immunoassay, and is 
suitable for POC and field testing in resource-permitting settings. The experimental results 
demonstrated its tremendous potential and use as a diagnostic tool. The use of the compact 
micro-channels for antibody and/or antigen immobilization and its immunogenicity 
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detection is a viable way to increase the sensitivity and enhance the reaction efficiency of 
the system for use in laboratory settings or research. Additionally, the PDMS-based 
micro-device rendered the immunoassay simple to use and importantly cost-efficient to 
use. The system can be feasibly modified to complete multiple measurements with 
numerous advantages as noted and potentially revolutionizing the diagnosis of diseases as 
POC system or in the field.  
The developed microarray system is a simple and portable device with easy 
performance as warranted for the diagnosis of infectious diseases, especially in 
resource-limited settings and on-line assays. The microarray system can also be easily 
expanded to test additional samples and analytes in parallel. The method has excellent 
compatibility for routine immunoassays that are used in diagnostics, and field testing for 
medical and clinical diagnosis, as well as high potential to be integrated into a portable 
system of POC supporting public health in the future. 
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